Do Nutrients Counteract the Acute Cardiovascular Effects of Air Particles? The Role of Immuno-Epigenetics in Observational and Intervention Studies by Zhong, Jia
Do Nutrients Counteract the Acute
Cardiovascular Effects of Air Particles?
The Role of Immuno-Epigenetics in
Observational and Intervention Studies
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Zhong, Jia. 2016. Do Nutrients Counteract the Acute Cardiovascular
Effects of Air Particles? The Role of Immuno-Epigenetics in
Observational and Intervention Studies. Doctoral dissertation,
Harvard T.H. Chan School of Public Health.
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:27201716
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
 
 
Do Nutrients Counteract the Acute Cardiovascular Effects of Air 
Particles? 
The Role of Immuno-epigenetics in Observational and Intervention 
Studies 
Jia Zhong 
 
A Dissertation Submitted to the Faculty of 
The Harvard T.H. Chan School of Public Health 
in Partial Fulfillment of the Requirements 
for the Degree of Doctor of Science 
in the Department of Environmental Health 
Harvard University 
Boston, Massachusetts 
 
May 2016
ii 
 
Dissertation Advisor: Dr. Andrea Baccarelli                           Jia Zhong 
Do Nutrients Counteract the Acute Cardiovascular Effects of Air Particles? 
The Role of Immuno-epigenetics in Observational and Intervention Studies 
Abstract 
Background: Fine particulate matter (PM2.5) pollution is a major risk factor for cardiovascular 
diseases. Identifying modifiable factors and preventative strategies to mitigate the cardiovascular 
effect of PM2.5 is essential to aid the development of personalized intervention. 
Method: Chapter one and two were based on a crossover human intervention trial using B 
vitamin supplementation (2.5 mg/d folic acid, 50 mg/d vitamin B6, and 1 mg/d vitamin B12). Ten 
volunteer received three two-hour controlled exposure experiments to medical air or PM2.5 
(250µg/m3), in pre-determined order. Chapter three utilized the Normative Aging Study, a 
longitudinal cohort study with 573 elderly men. We used electrocardiogram to measure resting 
heart rate (HR) and heart rate variability (HRV), hematology analyzer to determine white blood 
cell (WBC) counts, and Infinium HumanMethylation450 BeadChip to measure DNA 
methylation in peripheral CD4+ T helper (Th) cells (pre-, post-, 24-hr post-exposure). Blood 
TLR2 methylation was analyzed using pyrosequencing. Daily flavonoid and methyl nutrients 
intakes were assessed through the Food Frequency Questionnaire. 
Results: Compared to medical air, PM2.5 exposure was associated with 3.8 beat/min (95% CI, 
0.3, 7.4; P=0.04) higher resting HR, 57.5% (95% CI, 2.5%, 81.5%; P=0.04) lower low-
frequency (LF) power, and altered DNA methylation landscape, following exposure. PM2.5 
exposure was associated with 11.5% (95% CI, 0.3%, 24.0%; P=0.04) higher total WBC count 
and 12.9% (95% CI, 4.4%, 22.1%; P=0.005) higher lymphocyte count, at 24-hour post-exposure. 
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These effects of PM2.5 were abrogated with B vitamins supplement. In the Normative Aging 
Study, every 10 !g/m3 increase in 48-hour PM2.5 moving average was associated with 7.74% 
(95%CI: -1.21%, 15.90%; P=0.09), 7.46% (95%CI: 0.99%, 13.50%; P=0.02), 14.18% (95%CI, 
1.14%, 25.49%; P=0.03), and 12.94% (95%CI, -2.36%, 25.96%; P=0.09) reductions in root 
mean square of successive differences (rMSSD), standard deviation of normal-to-normal 
intervals (SDNN), LF power, and high-frequency (HF) power, respectively. Higher TLR2 
methylation exacerbated the rMSSD, SDNN, LF, and HF reductions associated with heightened 
PM2.5 (Pinteraction=0.006, 0.03, 0.05, 0.04, respectively). Every interquartile-range increase in 
flavonoid intake was associated with 5.09% reduction in mean TLR2 methylation (95%CI, 
0.12%, 10.06%; P=0.05) and counteracted the effects of PM2.5 on LF (Pinteraction=0.05). 
Conclusions: Ambient PM2.5 exposure peak has unfavorable effect on cardiac autonomic 
function, the immune system, and the epigenome – which, can be counteracted by B vitamins 
supplementation. In addition, the epigenetic regulation of TLR2-related immunity may determine 
vulnerability of older individuals when confronted with air pollution peaks.!
  !
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1. Air pollution: impact on CVD and need for preventive strategies 
Particulate Matter (PM) has been estimated to contribute to 3.7 million deaths worldwide each 
year.11 According to the American Heart Association (AHA), PM exposure is a modifiable 
primary contributor to cardiovascular morbidity and mortality, often resulting from acute 
cardiovascular effects after short-term exposure peaks.2 PM2.5 is especially deleterious because it 
penetrates into the alveoli and may act as a stimulus to trigger local cytokine production and 
systemic inflammation.12, 13 The major sources of PM2.5 pollution are combustion activities 
(motor vehicles, power generation, and industrial processes), biomass burning, and other human 
activities such as heating and cooking.2 Because prevention of exposure to PM is particularly 
challenging—more than 80% of people in the United States (US) receive some exposure—it is 
essential to 1). determine molecular intervention targets underlying the cardiovascular effects of 
PM (Aim 1 and 2) (Fig. 1); 2). identify modifiable factors that contribute to individual 
susceptibility to cardiac effects to aid the development of effective interventions (Aim 3) (Fig. 
0.1). 
Figure 0.1: Proposed Conceptual Model 
 
 
2. Reduced HRV and elevated BP: ideal early markers of PM-induced cardiovascular 
system impairment 
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Impaired autonomic modulation of the rhythmic activity of the sinus node, as reflected in 
reduced HRV, represents a pathophysiologic mechanism by which air pollution may lead to 
cardiac mortality, especially among older individuals.14, 15 The negative association between 
short-term PM2.5 exposure and HRV has been repeatedly observed in general population,16 
cardiac and hypertensive patients,17 asthmatic adults,18 young adults,19 and elderly adults.20, 21 
Notably, HRV shows wide inter-individual variability, as well as highly variable responses to 
PM exposure.7 Therefore, HRV is an ideal early surrogate marker of cardiovascular autonomic 
dysfunction for identifying underlying factors that may modify susceptibility to cardiovascular 
effects of PM exposure. 
 
Further, effect of short-term exposure to PM on rapidly increased BP has been demonstrated in 
observational4, 5 and controlled human exposure studies to concentrated ambient particles 
(CAPs).22-25 In particular, the adverse effect of short-term ambient PM on BP has been observed 
in general population,26 healthy adults,24, 27 older adults,28 cardiac disease patients,4, 29 and 
patients with lung disease.30, 31 Our previous experiments of controlled human exposure to CAPs 
have reproducibly shown rapid adverse effects on BP as early as two hours after exposure to 
PM.22-25, 32 Taken together, elevated BP in response to air pollution peaks have been indicated as 
one of the primary intermediates leading to acute air pollution-related CVD events.2, 5  
 
3. Immuno-epigenetics: the dynamic epigenetic regulation of the immune system 
Growing evidence indicates that systemic inflammation not only is an essential mechanistic 
pathway linking adverse cardiovascular events following PM exposure,2, 33 but also exacerbates 
disturbances on autonomic modulation following PM exposure.8 Thus, the regulation of the 
immune system is critical to limiting immune-mediated cardiovascular pathology.10 DNA 
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methylation, the most studied epigenetic process, is shown to be a key mechanism modulating 
the activity of inflammatory genes post PM exposure.8, 9, 34-37 In turn, inflammation and oxidative 
stress can influence both global and gene-specific methylation. Taken together, these findings 
indicate the unique roles of this dynamic crosstalk between the epigenome and the immune 
system, and potential opportunity to target the epigenome for avoiding immune-mediated 
adverse cardiovascular effects.  
 
      3.1. Hypomethylation of inflammatory genes in T-helper (Th) cells: novel mechanism 
underlying the cardiovascular effects of air pollution Observational studies has repeatedly 
shown that PM exposure can induce hypomethylation in blood leukocyte DNA, particularly of 
inflammatory genes.8, 34-37 Based on these findings, blood leukocyte DNA hypomethylation has 
been indicated as a novel mechanism activating the expression of inflammatory genes and 
potentially linking PM inhalation to CVD effects.9 Th cells have been shown as a central blood 
cell type which responds to PM exposure peaks with rapid DNA demethylation and mediate 
acute cardiovascular effects. Hypomethylation and expression of inflammatory cytokines in Th 
cells were observed as early as 2 hours after an antigen challenge.38 Inhalation of diesel PM has 
been specifically linked to inflammatory responses and interferon-gamma hypomethylation in 
circulating Th cells from exposed rats.37 RAG-1-/- mice, which lack T cells, have markedly 
blunted hypertensive responses to angiotensin II and salt challenges, and researchers were able to 
reinstate the normal responses by restoring T cells to these animals.39 Subsequent studies have 
demonstrated that cytokines released by Th cells contributed to the observed phenomenon.40, 41 
These evidences have shown the critical roles for Th-cell mediated cytokines production in 
regulating the adaptive immunity and immune cell proliferative responses.42 In addition, recent 
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evidences suggested that Th cells are crucial players involved in vasoconstriction and 
hypertension. Mice lacking interleukin-17 (IL-17#/# mice), a Th17 cytokine, exhibit lower BP 
increases after angiotensin infusion, as well as reduced effects on endothelium-dependent 
vasodilatation.43 This growing body of work strongly suggests mechanistic roles for cytokines 
released from Th cells in the production of rapid adverse BP and endothelial responses.39, 40, 42-44  
 
      3.2. Hypermethylation of immune-regulatory gene TLR2: epigenetic susceptibility to PM-
induced cardiovascular effects Molecules involved in immunoresponses are attractive as 
potential modulators of cardiovascular pathology following PM exposure. Toll-like receptors 
(TLRs), a group of receptors abundantly expressed on leukocytes, have emerged as crucial first-
responders linking innate and adaptive immunity after environmental challenge.45 TLR2, in 
particular, is a unique TLR family member that not only assists the clearance of bacterial 
components contained in PM via pathogen recognition,46, 47 but also modulates the expansion 
and behavior of regulatory T cells (Treg)—the dominant circulating regulator of 
immunosuppression.48, 49 Netea et al. reported a 50% decrease in the number of CD4+CD25+ 
Treg cells accompanied by an impaired release of immunosuppressive cytokines in TLR2 null 
mice compared with wild-type mice, demonstrating the role of TLR2 in immunoregulation.49 
These findings support our hypothesis that high TLR2 methylation, an epigenetic process 
associated with suppressed TLR2 expression, conveys susceptibility to PM exposure-induced 
HRV reductions by decreasing immunoregulation. TLR2-related immunity is controlled through 
epigenetic mechanisms: increased methylation in the TLR2 promoter region is usually associated 
with TLR2 silencing, while decreased methylation permits TLR2 expression.50 Therefore, 
maintaining a proper methylation level of the TLR2 gene is critical to ensure protective immunity, 
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while dysregulated TLR2 level might contributes to “epigenetic susceptibility” for immune-
mediated PM-induced cardiovascular responses. 
 
4. Flavonoid and methyl-donors: Unique opportunities for human translation of animal 
findings  
DNA methylation is reversible, thereby providing unique opportunities for modulation. This 
feature is critical, particularly for pathologies related to non-preventable exposures, as it can 
offer potential interventions to ameliorate exposure-related disease. Nutrients such as flavonoids 
and methyl nutrients can modify gene-specific methylation in opposite directions.51-54 Flavonoids, 
the most common group of polyphenolic compounds in the human diet, can lower DNA 
methylation and inhibit methylation-induced gene silencing.52, 53 Specifically, flavonoids inhibit 
the activity of DNA methyltransferase, reverse DNA hypermethylation and can reactivate 
silenced genes.52, 53 Lee and coauthors demonstrated a negative dose-response relationship 
between flavonoid concentration and enzyme-mediated DNA methylation.55 Methyl nutrients, on 
the other hand, may increase methylation by providing methyl donors.54 Thus, determining how 
such nutrients alter methylation states can provide insight that may be used to counteract 
exposure effects. 
 
The observation that PM induces DNA hypomethylation opens up an unprecedented opportunity 
for human translation of epigenetic modulation that has been successfully used in animal 
models.56 DNA methylation is dependent on a biochemical cycle relying on dietary methyl 
donors, including folic acid, vitamin B6 and B12, and methionine.57, 58 The classic Agouti Avy 
mice experiments have shown that dietary methyl donors supplement during gestation57, 59 or in 
adult life60-62 can increase DNA methylation. Dolinoy et al.63 showed that methyl donors can 
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avert Bisphenol A-induced hypomethylation, suggested the potential use of methyl donors to 
protect the adverse effect of environmental toxins. In epidemiological studies, methyl donor 
intake/plasma methyl donor is positively associated with global blood DNA methylation status in 
adults.64-66 Further, cultured human T cells undergo gene demethylation when challenged with 
low folate and methionine culturing environment.67 Taken together, these findings suggested the 
critical impact of methyl donor on DNA methylation in adults, and highlighted that DNA 
methylation in T cells is specifically dependent on methyl donor availability.  
 
No study has yet investigated whether DNA methylation and nutrient intake may modulate the 
cardiovascular effects of air pollution exposure. In Aim 1 and 2, we aim to address a 
fundamental pharmacologic and mechanistic question: does exposure have epigenetic effects 
with downstream subclinical/clinical cardiovascular consequences, and can adverse effects be 
safely reduced pharmacologically? In Aim 3, we hypothesize that programming of TLR2 
inactivation by increased methylation contributes to “epigenetic susceptibility” for immune-
mediated PM-induced cardiovascular responses, and dietary nutrients intake could affect the 
epigenetic programming of TLR2.  
 
INNOVATION: To the best of our knowledge, our study will be the first to: 1. test the effects of 
a human intervention and translate a wealth of animal data showing that methyl-donors can be 
used to modulate epigenetic states and avert environmental effects (Aim 1); 2. utilize controlled 
human exposure to PM, an approach that can reproduce ambient peaks of PM exposure (Aim 1 
and 2); 3. examine DNA methylation and expression in isolated Th, a key cell type mediating 
hypertensive responses (Aim 2); 4. test the role of the interplay between nutrient intake and DNA 
methylation on pollution-induced cardiovascular responses (Aim 3). 
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Chapter 1 
 
A Human Intervention Trial: Effects of Fine Concentrated Ambient Particles on Cardiac 
Autonomic Dysfunction and Inflammation Are Mitigated by B vitamin supplement 
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Background: Ambient fine particulate matter (PM2.5) pollution is a trigger of acute 
cardiovascular events. Individual-level preventions have been proposed to complement 
regulation in reducing the global burden of PM2.5–related cardiovascular diseases. We 
investigated whether B vitamins mitigate the acute effects of PM2.5 on cardiac autonomic 
dysfunction and inflammation. 
Methods: In a crossover human intervention trial, we administrated placebo and then four-week 
B vitamin supplement (2.5 mg/d folic acid, 50 mg/d vitamin B6, and 1 mg/d vitamin B12) to ten 
healthy volunteers. Each volunteer received three two-hour controlled exposure experiments to 
medical air or PM2.5 (250µg/m3), in pre-determined order. We used electrocardiogram to measure 
resting heart rate (HR) and heart rate variability (HRV), and hematology analyzer to determine 
white blood cell (WBC) counts (pre-, post-, 24-hr post-exposure).  
Results: Compared to medical air, PM2.5 exposure was associated with 3.8 beat/min (95% CI, 0.3, 
7.4; P=0.04) higher resting HR and 57.5% (95% CI, 2.5%, 81.5%; P=0.04) lower low-frequency 
power following exposure. PM2.5 exposure was associated with 11.5% (95% CI, 0.3%, 24.0%; 
P=0.04) higher total WBC count and 12.9% (95% CI, 4.4%, 22.1%; P=0.005) higher 
lymphocyte count, at 24-hour post-exposure. These PM2.5 effects were mitigated by B vitamin 
supplement – which attenuated the effect of PM2.5 on HR by 90% (P=0.003), low-frequency 
power by 96% (P=0.01), total WBC count by 139% (P=0.006), and lymphocyte count by 106% 
(P=0.02).  
Conclusions: In healthy adults, two-hour PM2.5 exposure substantially increases HR, reduces 
HRV, and increases WBC. These effects were curbed by four-week B vitamin supplement. 
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INTRODUCTION 
Ambient fine particulate matter (PM2.5) pollution accounts for 3.7 million premature deaths per 
year worldwide, predominantly due to its acute effects on the cardiovascular system.1 A recent 
meta-analysis concluded that PM pollution is the most frequent trigger for myocardial infarction 
at the population level.2 Even at levels below the current National Air Quality Standards, 
associations of PM2.5 exposure with increased cardiovascular risk have been found in sensitive 
individuals.3,4 Moreover, many urban areas outside of North America continue to have elevated 
levels of PM2.5 pollution.1,5 Definition of options for individual-level prevention that may 
complement regulation to reduce the global burden of cardiovascular disease (CVD) due to 
ambient PM2.5 pollution represents a critical gap in current knowledge.4  
 
Reduced heart rate variability (HRV), reflecting perturbation of autonomic function,6,7 is a 
sensitive marker that can change rapidly in response to PM2.5 exposure.3 It represents a primary 
pathophysiologic intermediate that might leads to PM-related adverse cardiovascular events.4 In 
the Normative Aging Study, we found that the associations of short-term PM2.5 exposure with 
reduced HRV was limited to subjects with lower intakes of vitamin B6 or B12 and was abrogated 
in those with higher intakes.6 These findings suggest that B vitamins provide protection against 
the effect of PM2.5 on the autonomic nervous system.  
 
Higher B vitamins (folic acid, vitamins B6, and B12) intake is associated with decreased CVD 
risk in epidemiologic studies.8,9 However, to date, the results from randomized clinical trials do 
not support the benefit of B vitamin supplementation for CVD prevention.10-15 Recent studies 
suggest that B vitamins might be effective to minimize health effects of environmental stressors 
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because of its anti-inflammatory and antioxidant properties.!6,16 In animal models, B vitamin 
supplementation has been successfully used to curb the oxidative stress, inflammation, and 
metabolic phenotype change due to environmental stressors.17,18 However, no clinical trial has 
yet investigated whether B vitamin supplementation impacts the biologic response to ambient air 
pollution exposure.  
 
Our study is the first human trial to evaluate whether B vitamin supplementation (folic acid, 
vitamin B6 and B12) can curb the acute autonomic effects of PM2.5. We conducted a single-blind 
crossover intervention trial with controlled human exposure experiments to fine concentrated 
ambient particles (fine CAP, or PM2.5), on ten healthy adults. Because of the central role of 
inflammation in modulating the cardiovascular effects of PM2.5, we also investigated the PM2.5 
effect on total and differential white blood cell (WBC) counts, and the potential for B vitamins to 
counteract these effects.  
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METHODS 
Study population 
We recruited ten healthy, 18–60 year old, non-smoking volunteers who are not on any form of B 
vitamin supplement, from the University of Toronto campus and surrounding area. The trial was 
approved by all participating institutional review board and registered. All volunteers provided 
written informed consent before enrolling. The conduct of the trial was monitored by an 
independent data and safety monitoring committee. 
 
Study design  
We conducted a single-blind crossover intervention trial (Figure 1.1) with controlled exposure 
experiments (July 2013 to February 2014). A two-hour blank exposure experiment (exposure one, 
particle-free medical air) was included to provide baseline data. All volunteers then received 
placebo for four weeks preceding the two-hour exposure experiment to concentrated ambient 
PM2.5 (exposure two, 250 !g/m3). After exposure two, we administered B vitamin supplement 
for four weeks before the next two-hour exposure experiment to PM2.5 (exposure three, 250 
!g/m3). We used a four-week washout period between exposure experiments because it was 
judged to be sufficient to diminish the carryover effect of PM2.5 exposure,19,20 while minimizing 
the impact of seasonality and temporal trend on the source and composition of the concentrated 
ambient PM2.5. In order to ensure comparable conditions across all controlled exposure 
experiments to PM2.5, the present study could not randomize on the treatment (placebo vs B 
vitamins) sequence because vitamin B12 has a biological half-life longer than four months.21 
Study volunteers are blinded to exposure and treatment allocation. Based on our symptom survey, 
none of the volunteer was able to discern the exposure type for any exposure experiment.
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Figure 1.1 Study design: A cross-over intervention trial with controlled exposure experiments
Exposure One 
2 hours, medical air 
  
2wk 
(Run-in) 4wk 4wk 
Placebo Placebo B Vitamins 
Exposure Three 
2 hours, PM2.5 
  
Exposure Two 
2 hours, PM2.5 
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Exposure facility  
Harvard fine and coarse particle concentrators with a dilution control system delivered target-
concentration PM2.5,22 and the medical air exposures were generated as previously described.23 
The concentrated ambient PM2.5 air stream was delivered directly to the volunteer who is seated 
inside a 4.9 m3 (1.1 x 1.9 x 2.0 m) Lexan enclosure, at rest and breathing freely via an "oxygen 
type" facemask on his/her nose and mouth. During each exposure experiment to PM2.5, particles 
were collected on polycarbonate membrane filters and we monitored gravimetric determination 
of PM2.5 exposure mass concentration (!g/m3).  
 
Folic acid, vitamin B6, and vitamin B12 supplement 
We administered one placebo or B vitamin supplement (2.5 mg folic acid, 50 mg vitamin B6, and 
1 mg vitamin B12) daily. Preparation and packaging of the placebo and B vitamin supplement 
was done by an external lab (Jamieson Laboratory, Toronto, Canada) to ensure blinding. The 
coding used on the label was blinded to the volunteers. We monitored volunteers’ plasma folic 
acid, vitamin B6 and B12 levels prior to each exposure experiment. Self-administered validated 
semi-quantitative Food Frequency Questionnaire was used to assess dietary B vitamin intake at 
the first and the last visit, to rule out potential impact from diet.  
                                        
Heat rate, heart rate variability, and WBC measurement 
We measured supine resting heart rate (HR) and HRV using high-resolution (1 KHz sample rate) 
digital 12-lead holter electrocardiogram monitors (H12+ recorder, Mortara Instruments, 
Milwaukee, WI). We obtained HRV measurements before (pre-exposure) and after (immediately 
post-exposure and 24-hour post-exposure) each exposure experiment. We extracted ten-minute 
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resting supine HRV readings on time domain outcomes (standard deviation of NN intervals 
(SDNN), square root of the mean squared differences of successive NN intervals (rMSSD), 
proportion of successive NN intervals with differences > 50 msec (pNN50)) and frequency 
domain outcomes (low-frequency (LF) power, high-frequency (HF) power, and their ratio 
(LF/HF)).24 We discarded the first three minutes and the last two minutes during the ten-minute 
recording and analyzed the remaining five-minute electrocardiogram data using standardized 
techniques.25 SDNN represents the total variability. PNN50, rMSSD, and HF are sensitive to 
high-frequency heart rate fluctuations and are considered as measures of cardiac vagal tone 
modulation, while LF power is linked to the activity of both sympathetic and parasympathetic 
nervous system.  
 
Blood samples (pre-, post-, and 24 hour post-exposure) were obtained in EDTA vacutainer tubes 
and stored at 4 °C, and subsequently processed in a local laboratory within two hours for total 
and differential WBC counts using the Technicon H-1 automated hematology analyzer 
(Technicon Instruments Corp, Terrytown, NY, USA).  
 
Statistical methods  
We conducted graphical explorations and log10-transformed HRV measures and WBC counts to 
improve normality and stabilize the variance.19 We examined the linear relationships between 
HR/HRV/WBC and all independent variables and covariates, and observed no deviation from 
linearity. For the ease of interpretation, we scaled the effect estimates to the percent changes in 
HRV and WBC in all models. 
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We used linear mixed-effects models with a robust/sandwich estimator for the variance (Model 1) 
to account for within-subject correlation in the outcome measures. Random intercepts were 
assigned to each subject. In all models, we adjusted for covariates with potential influences on 
HR, HRV, and WBC, selected based on prior knowledge and the existing literature, i.e., season 
(fall/winter/spring/summer), chamber temperature, and relative humidity.15,16  
Yij = "0 + "1 X1ij + "2X1ij*X2ij + "3X3ij + … + "pXpij + bi + #ij      (Model 1) 
In the above model, Yij was the change in HR, HRV, or WBC (i.e., $HR= post-exposure HR – 
pre-exposure HR) for participant i at exposure occasion j. !0 was the overall intercept, and bi was 
the separate random intercept for subject i with, bi ~ N(0, %), "ij ~ N(0, &2). X1ij was a binary 
variable indicating exposure to PM2.5 or medical air. X2ij was a binary variable indicating placebo 
or B vitamin supplement. X3ij–Xpij were the covariates, for participant i at measurement j. The 
main effect of B vitamin supplement was not included in the model, given volunteers did not 
receive any medical air exposure while on B vitamin supplement. !1 represents the effect of 
PM2.5 exposure (without B vitamin supplement) and !2 represents the effect modification by B 
vitamin supplement. A two tailed value of P '0.05 was considered statistically significant. 
Analyses were performed using SAS 9.4 (SAS Institute, Cary NC).  
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RESULTS 
Study population characteristics and exposure levels 
All volunteers completed three controlled exposure experiments. Four volunteers were white, 
three were Asian, and three were other races. Six volunteers were female and three had a BMI 
(25 (Table 1.1). The baseline mean resting HR was 58.9 beat/min (range: 43.0 to 74.0 beat/min). 
The baseline resting HR did not vary substantially by age, gender, race, or being overweight 
(Table 1.1).  
 
The target PM2.5 concentrations were controlled by design; however, there was some variation in 
the actual PM2.5 concentration (Table 1.2). Among all controlled exposures to PM2.5, PM2.5 
concentration varied from 100.6 !g/m3 to 287.5 !g/m3, with a median of 234.0 !g/m3. Previous 
studies using the same exposure facility reported minimal concentration of PM2.5 in medical air 
(median=0.0 !g/m3, interquartile range=2.40 !g/m3).19 There was no significant difference in 
PM2.5 concentration between exposure 2 and 3 (P=0.38) (Table 1.2).  
 
Plasma concentrations of B vitamins 
Four-week B vitamin supplement significantly increased the plasma concentration of folic acid, 
vitamins B6 and B12 (P=0.02, P=0.004, P=0.01; respectively), while placebo did not alter the 
plasma folic acid, vitamins B6 and B12 levels (P=0.82, P=0.75, P=0.42; respectively) (Table 1.3). 
 
Effect of PM2.5 on HR, HRV, and WBC without B vitamin supplement 
In the absence of B vitamin supplement, PM2.5 exposure increased HR and lowered HRV after 
exposure (Table 1.4). Compared to medical air, two-hour PM2.5 exposure was associated with 3.8  
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Table 1.1 Baseline characteristics of the study participants (N=10) 
Characteristics N (%) 
Resting Heart Rate 
Mean (SD) 
Age (years)   
19-29 7 (70) 62.3 (8.1) 
30-49 3 (30) 51.0 (7.0) 
   
Gender   
Female 6 (60) 61.0 (8.9) 
Male 4 (40) 55.8 (10.0) 
   
Race   
White  4 (40) 52.0 (6.2) 
Asian 3 (30) 64.3 (8.5) 
Other 3 (30) 62.7 (9.5) 
   
BMI (kg/m2)   
<25 7 (70) 62.1 (8.2) 
(25 3 (30) 51.3 (7.6) 
SD indicates standard deviation; BMI indicates body mass 
index.
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Table 1.2 Total exposure mass concentration of fine particles (PM2.5) across three exposure experiments 
Exposure* Mean (SD) Median (IQR) Maximum Minimum P for T test 
Exposure 1 (Medical Air + Placebo) (!g/m3) -- -- -- -- -- 
Exposure 2 (PM2.5 + Placebo) (!g/m3) 217.1 (50.6) 219.1 (33.1) 100.6 287.5 
0.38 
Exposure 3 (PM2.5 + B vitamins)  (!g/m3) 233.8 (31.2) 237.2 (48.7) 184.6 286.2 
SD indicates standard deviation; IQR indicates inter-quartile range. 
*Integrated gravimetric (filter sample) 2-hour exposure concentrations sampled from PM2.5/medical air airstream inlet to 
human exposure chamber.  
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Table 1.3 Plasma concentration of folic acid, vitamin B6 and B12, prior to each exposure 
experiment 
  Mean (SD) Median (IQR) Minimum Maximum P* 
 Prior to Exposure 1 (Medical Air + Placebo)  
Folic acid (nmoles/L) 37 (9) 35 (14) 28 56 -- 
B6 (nmoles/L) 42 (11) 41 (1) 25 57 -- 
B12 (pmoles/L) 305 (107) 292 (72) 173 486 -- 
      
!
Prior to Exposure 2 (PM2.5 + Placebo)  
Folic acid (nmoles/L) 39 (13) 39 (24) 22 56 0.82 
B6 (nmoles/L) 87 (142) 37 (18) 19 482 0.75 
B12 (pmoles/L) 302 (99) 262 (214) 197 441 0.42 
      
!
Prior to Exposure 3 (PM2.5 + B vitamins)  
Folic acid (nmoles/L) 124 (186) 56 (13) 27 638 0.02 
B6 (nmoles/L) 393 (224) 428 (321) 23 708 0.004 
B12 (pmoles/L) 507 (166) 511 (85) 176 794 0.01 
SD indicates standard deviation; IQR indicates inter-quartile range. 
*P value from the Wilcoxon signed-rank test, the measurement took prior to Exposure 1 
was used as the reference group.
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Table 1.4 Immediate change of post- vs pre-exposure heart rate (HR) and heart rate variability (HRV) associated with two-hour 
exposure to fine particles (PM2.5), and the attenuated PM2.5 effect due to B vitamin supplement (N=10) 
  Effect of PM2.5 without  B vitamin supplement   
Effect of PM2.5 with B vitamin 
supplement     
Outcome Estimate P 95% CI ! Estimate P 95% CI  
P for 
interaction 
!HR (beat/min) 3.84 0.04 0.29 to 7.40 ! -1.93 0.14 -4.59 to 0.73  0.003 
 ! ! ! ! ! ! ! ! !
 % Change* P 95% CI ! % Change* P 95% CI   
Time Domain    !      
!SDNN -33.56 0.06 -56.75 to 2.05 ! -14.55 0.47 -45.62 to 34.28  0.16 
!rMSSD -14.80 0.25 -35.92 to 13.27 ! -0.39 0.97 -23.05 to 28.94  0.26 
!PNN50 -29.92 0.15 -57.37 to 15.22 ! -6.78 0.79 -46.42 to 62.18  0.15 
    !      
Frequency Domain    !      
!LF -57.49 0.04 -81.47 to -2.50 ! -5.79 0.89 -61.03 to 127.76  0.01 
!HF -34.32 0.20 -66.23 to 27.72 ! -6.47 0.81 -48.18 to 68.82  0.19 
!LF/HF -35.93 0.09 -61.81 to 7.50   -1.56 0.94 -37.49 to 55.01   0.06 
HR indicates heart rate; SDNN indicates the standard deviation of normal-to-normal (NN) intervals; rMSSD indicates the root 
mean square of successive differences; PNN50 indicates percentage of differences between adjacent NN intervals that are greater 
than 50 milliseconds; LF indicates low-frequency power (0.04 –0.15 Hz); HF indicates high-frequency power (0.15–0.4 Hz).  
* Represents the % change in post-exposure HRV/pre-exposure HRV ratio associated with PM2.5 exposure, compared to medical 
air. Results were adjusted for chamber humidity, chamber temperature, and season (Spring/Summer/Fall/Winter). 
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beat/min (95% CI, 0.3 beat/min, 7.4 beat/min; P=0.04) higher resting HR. PM2.5 exposure was 
associated with 33.6% (95% CI, -2.1%, 56.8%; P=0.06), 57.5% (95% CI, 2.5%, 81.5%; P=0.04), 
and 35.9% (95% CI, -7.5%, 61.8%; P=0.09) lower SDNN, LF, and LF/HF ratio compared to 
medical air, respectively (Table 1.4). At 24-hour post-exposure, we did not observe any 
significant effect of PM2.5 exposure on HR or HRV (Table 1.5).  
 
Exposure to PM2.5 increased total and differential WBC counts, compared to medical air (Table 
1.6). Immediately after exposure, PM2.5 was associated with 9.9% (95% CI, -0.8%, 21.8%; 
P=0.07) and 10.0% (95% CI, -1.7%, 23.2%; P=0.09) higher numbers of total WBC and 
lymphocyte (Table 1.6). At 24-hour post-exposure, PM2.5 exposure was associated with 11.5% 
(95% CI, 0.3%, 24.0%; P=0.04) and 12.9% (95% CI, 4.4%, 22.1%; P=0.005) higher numbers of 
total WBC, neutrophil, lymphocyte, and monocyte, respectively (Table 1.6). 
 
B vitamin supplement attenuated the effects of PM2.5  
After four-weeks of B vitamin supplementation, the associations were significantly attenuated.  
For example, the association of PM2.5 with post-exposure HR (P for interaction=0.003), HRV (P 
for interaction=0.01 for LF), and total WBC count (P for interaction=0.008). The effect of PM2.5 
on HR was diminished and was no longer significant with B vitamin supplement (-1.9 beat/min, 
95% CI, -4.6 beat/min, 0.7 beat/min; P=0.14) (Table 1.4). Likewise, B vitamin supplementation 
resulted in a reduction in the effect size of PM2.5 by 90% for LF, and 96% for LF/HF ratio (Table 
4). With B vitamin supplement, exposure to two-hour PM2.5 was associated with 5.8% (95% CI, -
127.8%, 61.0%; P=0.89; P for interaction=0.01) and 1.6% (95% CI, -55.0%, 37.5%; P=0.94; P 
for interaction=0.06) lower LF and LF/HF ratio, respectively (Table 1.4). In addition, although  
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Table 1.5 Change of 24-hour post- vs pre-exposure heart rate (HR) and heart rate variability (HRV) associated with two-hour 
exposure to fine particles (PM2.5), and the attenuated PM2.5 effect due to B vitamin supplement (N=10) 
  Effect of PM2.5 without  B vitamin supplement   
Effect of PM2.5 with B vitamin 
supplement     
Outcome Estimate P 95% CI ! Estimate P 95% CI  
P for 
interaction 
!HR (beat/min) 1.71 0.37 -2.29 to 5.71 ! -0.35 0.89 -5.70 to 5.01  0.003 
! ! ! ! ! ! ! ! ! !
! % Change* P 95% CI ! % Change* P 95% CI   
Time Domain    !      
!SDNN -0.43 0.98 -26.25 to 34.45 ! 10.95 0.46 -17.59 to 49.39  0.54 
!rMSSD -21.87 0.16 -45.40 to 11.81 ! 10.23 0.60 -26.19 to 64.61  0.01 
!PNN50 -26.28 0.43 -67.73 to 68.40 ! 38.88 0.42 -41.70 to 230.88  0.03 
    !      
Frequency Domain    !      
!LF 8.37 0.62 -23.67 to 53.87 ! 58.34 0.08 -5.54 to 165.40  0.13 
!HF -27.54 0.38 -66.45 to 56.51 ! 41.97 0.39 -39.82 to 234.88  0.06 
!LF/HF 26.70 0.57 -48.15 to 209.61   19.77 0.59 -41.33 to 144.54   0.90 
HR indicates heart rate; SDNN indicates the standard deviation of normal-to-normal (NN) intervals; rMSSD indicates the root 
mean square of successive differences; PNN(10/20/50) indicates percentage of differences between adjacent NN intervals that are 
greater than (10/20/50) milliseconds; LF indicates low-frequency power (0.04 –0.15 Hz); HF indicates high-frequency power 
(0.15–0.4 Hz).  
* Represents the % change in 24-hour post-exposure HRV/pre-exposure HRV ratio associated with PM2.5 exposure, compared to 
medical air. Results were adjusted for chamber humidity, chamber temperature, and season (Spring/Summer/Fall/Winter). 
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Table 1.6 Change of white blood cell (WBC) counts and distribution associated with two-hour exposure to fine particles 
(PM2.5), and the attenuated PM2.5 effect due to B vitamins treatment (N=10) 
  Effect of PM2.5 without  B vitamin supplement   
Effect of PM2.5 with B vitamin 
supplement     
! % Change* P 95% CI  % Change* P 95% CI  
P for 
interaction 
! Immediate post-pre change in WBC   
!WBC 9.89 0.07 -0.82 to 21.75  -1.68 0.67 -9.57 to 6.90 ! 0.008 
!Neutrophil 8.93 0.28 -7.47 to 28.22  -3.07 0.68 -17.41 to 13.77  0.06 
!Lymphocyte 10.02 0.09 -1.70 to 23.16  2.36 0.62 -7.37 to 13.11  0.09 
!Monocyte 6.53 0.62 -18.81 to 39.77  1.63 0.86 -16.59 to 23.85  0.63 
          
! 24-hour post-pre change in WBC   
!WBC 11.54 0.04 0.34 to 23.99  -4.48 0.43 -15.52 to 7.99  0.006 
!Neutrophil 12.94 0.15 -4.91 to 34.13  -8.40 0.32 -23.62 to 9.86  0.01 
!Lymphocyte 12.91 0.005 4.41 to 22.10  -0.82 0.87 -11.18 to 10.73  0.02 
!Monocyte 5.23 0.36 -6.41 to 18.33   7.48 0.31 -7.34 to 24.67   0.61 
* Represents the % change in post-exposure cell count/pre-exposure cell count ratio associated with PM2.5 exposure, 
compared to medical air. Results were adjusted for chamber humidity, chamber temperature, and season 
(Spring/Summer/Fall/Winter). 
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non-significant, B vitamin supplement attenuated the PM2.5 effect by 57% on SDNN, 97% on 
rMSSD, 77% on PNN50, and 81% on HF (Table 1.4).  
 
The effect attenuation by B vitamins on the PM2.5-HR or PM2.5-HRV relationship (P for 
interaction=0.003, 0.01, 0.03 for HR, rMSSD, and PNN50, respectively) remained significant, at 
24-hour post-exposure (Table 1.5).  
 
The associations of PM2.5 with post-exposure total and differential WBC counts were weakened 
by B vitamin supplement (Table 1.6). Compared to medical air, effects of PM2.5 on WBCs were 
diminished to non-significant with B vitamin supplement: two-hour PM2.5 exposure was 
associated with a -1.7% (95% CI, -9.6%, 6.9%; P=0.67; P for interaction=0.008), -3.1% (95% CI, 
-17.4%, 13.8%; P=0.68; P for interaction=0.06), and 2.4% (95% CI, -7.4%, 13.1%; P=0.62; P 
for interaction=0.09) change in total WBC, neutrophil, and lymphocyte, respectively (Table 1.4). 
In summary, B vitamin supplement reduced the PM2.5 effect by 117%, 134%, 76%, and 75% on 
total WBC, neutrophil, lymphocyte, and monocyte, respectively (Table 1.6). B vitamin 
supplement non-significantly attenuated the association of PM2.5 with monocyte (Table 1.6). 
 
Likewise, at 24-hour post-exposure, B vitamin supplement attenuated the PM2.5 effects on total 
and differential WBC counts (P for interaction=0.006, 0.01, 0.02, 0.61 for total WBC, neutrophil, 
lymphocyte, and monocyte) (Table 1.6). B vitamin supplement significantly reduced the PM2.5 
effect by 139% on total WBC, 167% on neutrophil, and 106% on lymphocyte (Table 1.6).  
 
Sensitivity analysis 
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We dealt with potential influence by season via adjusting for spring/summer/fall/winter in all 
models. In sensitivity analysis, we additionally adjusted for seasonality (defined using sine and 
cosine functions)26 to further address residual confounding, and our conclusions remained the 
same (data not shown). In the PM2.5-HRV analysis, we additionally adjusted for HR to 
investigate if the change in HRV was partially due to HR fluctuation, and we obtained similar 
results (data not shown). We also ruled out confounding due to dietary intake of folic acid, 
vitamin B6 and B12, as no significant changes was observed during the study period 
(Supplementary Table 1.1). 
 37 
 
Supplementary Table 1.1 Dietary intake of folic acid, vitamin B6 and B12, at screening and the end of study 
  Mean (SD) Median (IQR) Range   Mean (SD) 
Median 
(IQR) Range   
P for 
T test 
 Screening  End of Study  !
Folic acid(mcg/d) 172.8 (105.7) 161.5 (143.0) 17.0 to 376.0  171.8 (121.7) 169.0 (130.0) 3.0 to 429.0  0.98 
B6 (mg/d) 2.1 (0.8) 2.2 (0.6) 0.3 to 3.6  2.0 (0.7) 2.0 (1.1) 0.9 to 3.2  0.86 
B12 (mcg/d) 6.5 (4.1) 5.6 (4.1) 0.9 to 13.4   5.6 (2.2) 6.8 (2.5) 1.3 to 7.6   0.57 
SD indicates standard deviation; IQR indicates inter-quartile range.  
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DISCUSSION AND CONCLUSION 
This single-blind crossover intervention trial with controlled exposure experiments found that 
two-hour exposure to concentrated ambient PM2.5 (250µ/m3) has substantial physiologic impacts 
on HR, HRV, and WBC among healthy adults. Furthermore, we demonstrated that these effects 
are nearly entirely abolished with four-weeks of B vitamin supplementation.  
 
Ambient PM2.5 pollution continues to be a major cardiovascular public health challenge facing 
the world today, with levels of pollution that are far higher than U.S. EPA National Ambient Air 
Quality Standards (NAAQS) in many urban megacities world-wide.27 Regulation remains the 
backbone of public health protection against cardiovascular health effects of particle pollution. 
Improvement in cardiovascular health with reduction in morbidity and mortality has been 
documented as pollution levels have decreased in the U.S.28 Nevertheless, even in U.S. cities in 
compliance with NAAQS, cardiovascular effects of particle pollution have been documented 
with no evidence for a threshold for effect in sensitive individuals.3,4,6,27 Thus the physician and 
public health community have sought adjunct personal measures that might complement 
regulation in reducing the cardiovascular risk of pollution in sensitive people.29  
 
Our choice to assess the potential benefits of B vitamin supplementation was motivated by the 
anti-inflammatory, antioxidant, and epigenetic effects of B vitamins.30,31 In addition, some 
observational and laboratory studies suggest that B vitamins might be particularly protective 
against air pollution-induced cardiovascular outcomes, and intermediate pathway 
biomarkers.6,17,30,31 For example, folic acid and vitamin B6 lowers circulating levels of pro-
inflammatory molecules,30,31 and attenuates lipopolysaccharide-induced nuclear factor-k! 
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pathway activation.16 In addition, adequate B vitamin intake ensures proper epigenetic status in 
WBCs – which warrants proper immuno-regulation and prevents excessive oxidative damage to 
the cardiovascular system.3,4 Although the results of randomized controlled trials on 
supplementation with folic acid, vitamin B6 and B12 do not support benefits of B vitamin 
supplement for either primary or secondary CVD prevention,12,14,15,32 the abovementioned 
interactive biological properties of B vitamins render it a promising preventive strategy to 
minimize the cardiovascular damage due to ambient PM2.5 pollution. However, no prior clinical 
investigation has tested whether B vitamins supplementation can be used to guard the 
cardiovascular system from the adverse health effects of PM2.5. 
 
Primary autonomic and WBC influences of PM2.5 
Our findings of a primary autonomic effect of PM2.5 are consistent with previous human 
controlled exposures studies,33-35 showing that short-term PM2.5 exposure perturbed 
cardiorespiratory autonomic function as reflected in increased HR and reduced HRV.6 
Immediately following two-hour exposure to ambient concentrated PM2.5, we observed a 
substantial increase in resting HR (3.8 beat/min) and a 57.5% reduction in LF power, compared 
to medical air. Our results indicate a consistent reduction in HRV across five measures – which 
reflects the adverse pathophysiological modulations in cardiac autonomic control by PM2.5 
exposure.  
 
PM2.5 is a potent trigger for leukocyte-mediated inflammation, which is proposed to be the key 
mechanism underlying the pathological modulation of the cardiovascular system by PM2.5 
exposure.4 Our data supports this hypothesis by showing that two-hour PM2.5 exposure 
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immediately triggers a 9.9% increase in total WBC count and a 10.0% increase in lymphocyte 
count (Table 1.6). In healthy adults, PM pollution has been shown to increase the number of 
neutrophil and lymphocyte in alveolar lavage and peripheral blood.36 While the underlying 
biological mechanism remains unclear, in vivo studies suggested that PM stimulates bone 
marrow via alveolar macrophages-mediated cytokine signaling, leading to accelerated release of 
immature leukocytes in to the circulation.37,38  
 
Twenty-four hours after the exposure, the effect of PM2.5 on HR and HRV weakened (Table 1.5). 
However, PM2.5 exposure remained significantly associated with >10% higher numbers of total 
WBC and lymphocyte (Table 1.6). Taken together, although the acute physiological responses 
due to PM2.5 exposure peak might be reversible, the pro-inflammatory effects of PM2.5 appears to 
be sustained beyond 24 hours and represent a biomarker of a process that could have clinical 
relevance to sensitive individuals in a community setting.4 
 
Modifying of PM2.5 autonomic and WBC effects by B vitamins 
For the first time, our trial provided evidences demonstrating the unique preventive benefits of B 
vitamin administration in the context of air pollution: B vitamin supplements can diminish the 
acute effects of PM2.5 on a battery of cardiac autonomic dysfunction measures and inflammatory 
markers. These findings are in line with our results from the Normative Aging Study6  – a 
population with average B vitamins intakes well above the standard dietary references – short-
term PM2.5 exposure was associated with lower HRV (7.1% reduction in SDNN per 10 "g/m3 
increase in PM2.5), and this effect was limited to subjects with lower (<median) intakes of 
vitamin B6, vitamin B12, or methionine.  
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This study has several strengths, including its crossover design with controlled exposure 
experiments – which simulate conditions similar to urban air pollution peaks, while allowing for 
control of exposure and treatment at the individual level. The Harvard ambient particle 
concentrators do not affect the concentration of gaseous pollutants, therefore, minimizing the 
confounding due to gaseous co-pollutants such as ozone and sulfur dioxide. All exposure 
experiments were conducted at the same time of the day to eliminate impact due to diurnal 
variation. We adjusted for time-varying factors including season, chamber temperature and 
humidity to minimize their influence on the observed associations, while time invariant factors 
are controlled by the crossover design. 
 
We acknowledge several limitations in the present study. Our study is underpowered to detect 
small effects with only 10 subjects (30 controlled exposure experiments). The present study 
could not randomize the treatment sequence due to the long half-life of B vitamins, therefore 
might be subject to confounding by period or ordering effects. For example, as the study 
progressed, the volunteers might be more tolerant with PM2.5 exposure because of learning effect. 
We intentionally provided medical air as the first exposure experiment; therefore the learning 
effect is expected to bias the effect of PM2.5 towards the null. The short study duration with only 
four-week time intervals between exposure experiments also reduced the impact of temporal 
trend. In addition, we contrasted the post- vs pre-exposure status to ascertain all outcome 
measurements, which is expected to be less prone to confounding due to temporal trend than the 
absolute values. While residual confounding is possible, considering the magnitude of our effect 
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estimates and the consistency across different HRV index, it is unlikely that the observed 
association reflected bias resulting from confounding.   
 
Apart from avoiding exercising outdoors at peak pollution times, sensitive individuals have 
limited personal options to reduce exposure and hence cardiovascular risk from ambient PM2.5 
pollution. While regulation is the backbone of prevention, residual risk remains for those who are 
sensitive, and high exposures are, unfortunately, the rule still in many megacities throughout the 
world. The present study for the first time provide experimental evidence showing that ambient 
PM2.5 exposure peak has unfavorable effect on cardiac autonomic function and the immune 
system, which, can be counteracted by B vitamin supplementation. Our project inaugurated a 
new line of research for the development of preventive pharmacological interventions to curb the 
health effect of air pollution. Future studies are warranted to identify the precise 
pathophysiological processes of PM-induced cardiovascular responses and inflammation, as well 
as the mechanistic pathway underlying the protective effect of B vitamins.  
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Chapter 2 
B Vitamins Curbs the Epigenetic Effect of Concentrated Ambient Fine Particles: An 
Epigenome-wide Association Study in a Human Intervention Trial 
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Background: Fine particulate matter (PM2.5) pollution alters DNA methylation status, a 
reversible epigenetic process underlying PM-induced inflammation and oxidative stress. We 
aimed to determine the genome-wide epigenetic effects of PM, and whether B vitamins 
supplement can avert these effects. 
Methods/Results: We conducted a crossover intervention trial with ten healthy adults. Each 
participant received placebos and then four-week B vitamins supplements (2.5 mg/d folic acid, 
50 mg/d vitamin B6, and 1 mg/d vitamin B12). Three two-hour controlled exposures to medical 
air or PM2.5 (250µg/m3) were administered in a pre-determined order. We measured the DNA 
methylation profile, pre and post each exposure, using the Infinium HumanMethylation450 
BeadChip in peripheral CD4+ T helper (Th) cells. Among ten top loci that were associated with 
PM exposure, two were involved in mitochondria oxidative metabolism. The effects of PM on 
these loci were attenuated with B vitamins supplement (P=0.003; P=0.01; P=0.0007; P=0.13; 
P=0.01; P=0.001; P=0.004; P=0.0004; P=0.0002; P=0.07). Motivated by these findings, we 
further assessed mitochondrial DNA content in CD4+ Th cells using quantitative polymerase 
chain reaction. At 24-hour post exposure, PM2.5 was associated with 8.11% (95% CI, 3.31%, 
12.91; P=0.002) lower mitochondrial DNA content compared to medical air. Effect of PM2.5 
were abrogated with B vitamins supplement – which attenuated the association of PM2.5 with 
mitochondrial DNA content by 105% (Pinteraction=0.02). 
Conclusions: In healthy adults, two-hour PM2.5 exposure substantially modulated the DNA 
methylation landscape and resulted in mitochondrial DNA depletion in circulating CD4+ Th cells. 
These effects can be mitigated with B vitamins supplement. 
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INTRODUCTION 
Ambient PM2.5 (particles with an aerodynamic diameter <2.5 micrometers) pollution, a major 
public health challenge facing the world today,1, 2 accounts for 3.7 million premature deaths per 
year.1 PM2.5 penetrates into the lower airways and chronically deposits in the respiratory 
bronchioles and the alveoli, stimulating local and systemic inflammation and oxidative stress.3, 4!
Each 10 "g/m3 elevation in annual PM2.5 exposure has been associated with an 11% increase in 
mortality.5 Over the past few decades, substantial lowering of ambient PM2.5 levels has been 
achieved by massive emission control efforts.6 However, exposure peaks with adverse health 
consequences are still frequently recorded in the United States,7, 8 even in areas with low usual 
levels.9 While the mechanism underlying PM2.5’s health effects remains the major gap in current 
knowledge, the lack of preventative options adds another layer of complexity to tackle this major 
public health challenge. 
 
Recent studies on environmental epigenetics provide tremendous opportunities to understand the 
mechanistic underpinning, and to develop novel interventions to be used at the personal level. 
DNA methylation, a reversible epigenetic mechanism, regulates gene expression via addition of 
methyl groups to the cytosine.10!Exposure to PM2.5 can rapidly alter the dynamic DNA landscape 
in peripheral leukocytes, which is postulated to underlie PM-induced systemic inflammation and 
oxidative stress.11-14 While most available evidence derives from human studies are based on a 
heterogeneous mixture of leukocytes,15-17 in vivo studies reported loss of methylation in 
inflammatory genes and subsequent inflammatory responses specifically in circulating T helper 
(Th) cells, after environmental challenge.18, 19  
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Notably, DNA methylation is dependent on a biochemical cycle that supplies methyl groups 
(CH3) while relying on methyl nutrients (i.e., B vitamins including folic acid, vitamin B6 and B12; 
and amino acids including methionine, betaine, and choline).10, 20, 21 In animal studies, a diet 
deficient in methyl nutrients leads to aberrant DNA methylation patterns,22, 23 and administration 
of methyl nutrients enables restoration of epigenetic status.14, 20, 24-27 Likewise, human studies 
showed the plasticity of DNA methylation in response to dietary methyl nutrients intervention.28 
Potential for epigenetic modulation was also demonstrated in the presence of environmental 
stressors – Dolinoy and coauthors successfully used methyl nutrients to avert the DNA 
hypomethylation induced by exposure to Bisphenol A.29 These findings have opened new 
avenues for the application of epigenetic intervention to reduce the health effects of air pollution. 
However, to date, human intervention study with epigenetic components in the context of air 
pollution is lacking.  
 
The present study is the first crossover intervention trial with controlled human exposure to fine 
concentrated ambient particles (fine CAP, or PM2.5). We hypothesized that acute PM2.5 exposure 
can rapidly modify the DNA methylation profile in CD4+ Th cells – the most prolific cytokine 
producer that mediates PM-induced inflammatory responses24,25 – and these effects can be 
curbed by intervention with B vitamins (i.e., folic acid, vitamin B6 and B12), an important source 
of methyl groups (Figure 2.1). 
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METHODS 
Study population 
We recruited ten healthy, 18–60 year old, non-smoking volunteers from the University of 
Toronto campus and surrounding area. All volunteers were not taking any medicines or vitamin 
supplements for at least more than four weeks before the enrollment. The study was approved by 
all participating institutes and registered. We obtained written informed consent from every 
volunteer before enrolling. 
 
Study design  
We conducted a single-blind, crossover, intervention trial with controlled exposure to 
concentrated ambient PM2.5 (July 2013 to February 2014). The design started with a two-week 
run-in period with placebo and then the baseline blank study (two-hour exposure to particle-free 
medical air, exposure one). After exposure one, each volunteer took placebo for four weeks and 
then exposed to PM2.5 (two hours, target concentration: 250 "g/m3, exposure two). All volunteers 
started the four-week B vitamins supplement right after exposure two, and then were exposed 
again to PM2.5 exposure (two hours, target concentration: 250 "g/m3, exposure three). 
 
Exposure facility  
We used the Harvard ambient particle concentrator, a 3-stage high-flow (5,000 L/min) virtual 
impactor, to generate concentrated ambient PM2.5.30 Ambient particles were drawn in from an 
inlet 1.5 meters high, beside a busy (>1,000 vehicles/hour) street in downtown Toronto. The 
PM2.5 air stream is delivered directly to the volunteer who is seated inside a 4.9 m3 (1.1 x 1.9 x 
2.0 m) lexan enclosure, at rest and breathing freely via an "oxygen type" facemask on his/her 
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Figure 2.1 Proposed conceptual model linking fine particulate matter (PM2.5) exposure, systemic oxidative stress and inflammation, 
and altered DNA methylation landscape in T helper cells 
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nose and mouth.!The Medical air exposures were generated as previously described.31 During 
each PM2.5 exposure experiment, particles were collected on polycarbonate membrane filters. 
The gravimetric determination of PM2.5 exposure mass concentration (!g/m3) was monitored. 
 
Folic acid, vitamin B6, and vitamin B12 supplement 
We administered one placebo or B vitamins supplement (2.5 mg folic acid, 50 mg vitamin B6, 
and 1 mg vitamin B12) daily to each volunteer. Preparation and packaging of the placebo and B 
vitamins supplement was done by an external lab (Jamieson Laboratory, Toronto, Canada) to 
ensure blinding. The coding used on the label was blinded to the volunteers and investigators. 
We monitored volunteers’ plasma folic acid, vitamin B6 and B12 levels prior to each exposure 
experiment. In addition, we assessed typical daily dietary intake of nutrients with a self-
administered validated semi-quantitative Food Frequency Questionnaire (FFQ) at the first and 
the last visit, to rule out potential impact from diet. 
 
T-helper cells isolation and DNA extraction  
We collected blood samples via venous phlebotomy, and within four hours, isolated CD4+ Th 
cells using negative selection (i.e. removal of other cell types). We targeted and removed 
unwanted cells using the RosetteSep® Human CD4+ T Cell Enrichment Cocktail (Stem Cell 
Technologies, #15062), without affecting CD4+ Th cells. DNA was extracted from isolated 
CD4+ Th cells using a Promega Maxwell 16 tissue DNA purification kit with a Promega 
Maxwell 16 instrument (Promega, Madison, WI). We monitored the concentration and quality of 
extracted DNA using NanoDrop ND-1000 spectrophotomer (Nanodrop Technologies, 
Oxfordshire, UK). Unsatisfactory DNA samples were discarded and re-extracted.  
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Epigenome-wide DNA methylation scan 
We diluted purified DNA samples to a concentration of 30 ng/ul, with a total volume of 40 ul 
(total amount: 1200 ng) and sent the de-identified samples to an external lab (Genomics Core 
Facility, Northwestern University) for bisulfite conversion and hybridization on the Infinium 
Human Methylation 450K BeadChip (Illumina, San Diego, CA, USA).32 The 450K BeadChip 
allows the assessment of approximately half a million CpG sites across 99% of RefSeq genes 
within the genome.16, 33, 34 Because of the within-subject cross-over design, we plated all samples 
from one subject in one chip, with pre- and post-exposure samples randomly loaded onto each 
column on the same row. All samples were processed by one technician and analyzed in one 
batch to minimize batch effect. We obtained the "-value for each CpG, derived from the 
fluorescent intensity ratio (" = intensity of the methylated allele/(intensity of the unmethylated 
allele + intensity of the methylated allele + 100)).  
 
Quality control for DNA methylation data 
Systematic QA/QC was performed, including assessment of assay repeatability and chip/plate 
effects using 10 across-chip technical replicates. We preprocessed the IDAT files using minfi 
package.35 We screened for signal outliers using multidimensional scaling analysis and no outlier 
were identified. We dropped the probes that are: 1.) where 20% of samples had detection P-
values >0.01 were dropped (n=441); 2.) assay SNPs rather than CpGs (n=65); 3). located on X or 
Y chromosome (n=11341). After excluding these probes, as well as control probes and probes on 
sex chromosomes, a total of 473,730 CpGs were analyzed. All samples had > 95% sites with 
detection p < 0.01. We checked gender concordance and did not observe any sample mismatch. 
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We minimized color channel bias and difference in Infinium chemistry by using dasen method in 
wateRmelon package to normalize36!"!which equalized type I and type II backgrounds first, and 
then quantile-normalized type I and type II intensities separately.  
 
Mitochondrial DNA content in CD4+ Th cells 
Motivated by the top loci associated with PM2.5 exposure, we measured mitochondrial DNA 
content in CD4+ Th cells through the mtDNA/nDNA ratio, a widely used biomarker representing 
the mitochondrial DNA copy number versus the nuclear DNA copy number.37, 38 Mitochondria 
DNA copy number was analyzed pre, post, and 24-hour post each exposure experiment using 
multiplex quantitative real-time polymerase chain reaction, as previously reported.39 The 
mtDNA/nDNA is used in the statistical analysis – a ratio value of 1 indicates that the 
mtDNA/nDNA of the test sample is equal to the mtDNA/nDNA in the reference DNA pool used 
in the assay. 
 
Statistical methods  
Covariates Selection and Model Assumption 
The crossover design minimized the influence from time-invariant factors (such as age, gender, 
race, etc.). In all models, we adjusted for covariates with potential influences on DNA 
methylation, selected based on prior knowledge and the existing literature, i.e., season 
(fall/winter/spring/summer), chamber temperature, and relative humidity.4, 31  
 
Linear mixed-effects models 
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Rank-based normal transformation was performed on all DNA methylation measures to improve 
normality and stabilize the variance.19 In the CpG-by-CpG analyses, we used linear mixed-
effects models (Model 1) to account for within-subject correlation in methylation measures. 
Random intercepts were assigned to each subject.  
Yij = "0 + "1PMij + "2PMij*Treatmentij + "3X1ij + … + "pXpij + bi + #ij      (Model 1) 
In the above model, Yij was the " value of the measured CpG probe for participant i at exposure 
occasion j, !0 was the overall intercept, and bi was the separate random intercept for subject i 
with, bi ~ N(0, $), "ij ~ N(0, %2). X1ij–Xpij were the covariates, for participant i at measurement j. 
The main effect of B vitamin supplementation was not included in the model, given volunteers 
did not receive any medical air exposure while on B vitamin supplementation. !1 represents the 
effect of PM2.5 exposure without B vitamin supplementation and !1 + !2 represents the effect of 
PM2.5 exposure with B vitamin supplementation. !2 thus represents the intervention effect of B 
vitamin supplementation (i.e, the attenuation of PM2.5 effect due to B vitamin supplementation). 
 
In addition, we used another linear mixed-effects model (Model 2) as secondary analysis to 
estimate the main effect of B vitamin supplementation assuming equivalent outcome status prior 
to exposure two and three.  
Yij = "0 + "1 Postij + "2Postij*PMij + "3Treatmentij + "4Treatmentij*Postij + "pX1ij … + "pXpij + bi 
+ #ij      (Model 2) 
For participant i at exposure occasion j, Postij (binary) indicates whether the methylation profile 
is measured pre- or post- exposure experiment; PMij (binary) indicates exposure to PM2.5 or 
medical air; Treatmentij (binary) indicates placebo or B vitamins supplement; X1ij–Xpij were the 
covariates. !1 represents the effect of exposure to medical air; !2 represents the effect of exposure 
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to PM2.5, compared to medical air; !3 represents the effect of B vitamins supplement;  !4 
represents the change in PM2.5 effect (comparing to medical air) when B vitamins supplement is 
added.  
 
Analyses were performed using SAS 9.4 (SAS Institute, Cary NC) and R statistical computing 
software (R Foundation for Statistical Computing, Vienna, Austria). Top associated loci were 
defined based on the effect size and P value of !2. The linear mixed-effects model was 
implemented using the lme440 and lmerTest41 packages.  
 
We estimated the proportions of major leukocyte types (CD4 T cells, CD8 T cells, B Cells, 
granulocytes, monocytes, and natural killer cells) to assess the purity of isolated CD4+ Th cells 
using the Houseman method, a statistical deconvolution technique based on the 450K data.15  
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RESULTS 
Study population, plasma B vitamins concentrations, and exposure levels 
Ten volunteers completed 30 controlled exposure experiments in total (10 medical air exposures 
and 20 PM2.5 exposures). Forty percent of the volunteers were white, 30% were Asian, and 30% 
were other races. Sixty percent of the volunteers were female and 30% had BMI &25 (Table 2.1). 
Table 1 presents the distributions of baseline mitochondrial DNA content across subgroups.  
 
We targeted the concentrations of PM2.5 at 287.5 !g/m3; however, the actual PM2.5 mass 
concentration varied among exposure experiments. In all controlled exposure experiments to 
PM2.5, the PM2.5 concentration varied from 100.6 !g/m3 to 287.5 !g/m3 with a median of 234.0 
!g/m3. There was no significant difference in PM2.5 concentration between exposure one and two 
(P=0.38).  
 
Prior to medical air exposure, the mean plasma concentration of folic acid, vitamin B6 and B12 
was 37 nmoles/L, 42 nmoles/L, and 305 pmoles/L, respectively. After taking placebos for four 
weeks, the mean plasma concentrations remained similar: 39 nmoles/L for folic acid (P=0.82), 
87 nmoles/L for vitamins B6 (P=0.75), and 305 pmoles/L for vitamins B12 (P=0.42). However, 
vitamins supplement significantly increased the mean plasma concentrations of folic acid (124 
nmoles/L, P=0.02), vitamin B6 (393 nmoles/L, P=0.004), and vitamin B12 (507 pmoles/L, 
P=0.01). 
 
CD4+ Th cells purity
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Table 2.1 Baseline characteristics of the study participants (N=10) 
Characteristics N (%) 
mtDNA copy number 
Mean (SD) Minimum Maximum 
Age (years)     
19-29 7 (70) 1.6 (0.1) 1.4 1.8 
30-49 3 (30) 2.0 (0.4) 1.6 2.4 
     
Race     
White  4 (40) 1.9 (0.3) 1.6 2.4 
Asian 3 (30) 1.5 (0.0) 1.5 1.6 
Other 3 (30) 1.6 (0.2) 1.4 1.7 
     
Gender     
Female 6 (60) 1.6 (0.1) 1.5 1.8 
Male 4 (40) 1.8 (0.4) 1.4 2.4 
     
BMI (kg/m2)     
<25 7 (70) 1.6 (0.1) 1.4 1.8 
&25 3 (30) 2.0 (0.4) 1.5 2.4 
mtDNA indicates mitochondrial DNA; SD indicates standard 
deviation; BMI indicates body mass index.
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Based on the Houseman cell proportion estimates, all CD4+ Th cell samples’ purity were over 
80% (Table 2.2). The median purity of CD4+ Th cell samples collected at exposure one, 
exposure two, and exposure three was 96.92%, 94.84%, and 96.09%, respectively. There was 
only minor contamination from CD8 T cells, B cells, granulocytes, and natural killer cells. 
 
Effect of PM2.5 and B vitamins supplement on DNA methylation 
We observed substantial modification of the DNA methylation landscape associated with PM2.5 
exposure and B vitamins supplement (Figure 2.2). Acknowledging that the present study is 
limited in power with only ten volunteers, we presented the top ten loci selected based on both 
effect size and P value (Table 2.3 and Figure 2.2), although no locus reached the Bonferroni 
threshold of significance.42 In the absence of B vitamins supplement, PM2.5 exposure for two 
hours was associated with both increased and decreased DNA methylation level compared to 
medical air exposure, immediately after exposure (Table 2.3). Quantile-Quantile plots for 
expected vs. observed distribution of P values showed minimal genomic inflation (Figure 2.3). 
Among the ten CpG sites, three were located on chromosome 2, two were located on 
chromosome 6, two were located on chromosome 19, and one each located on chromosomes 12, 
18, and 21. Five of the top loci were positively associated with exposure to PM2.5, while the other 
five top loci were negatively associated with exposure to PM2.5 (Table 2.3).  
 
Four-week B vitamins supplement attenuated the association of PM2.5 with all top loci 
(Pinteraction=0.003; Pinteraction=0.01; Pinteraction=0.0007; Pinteraction=0.13; Pinteraction=0.01; 
Pinteraction=0.001; Pinteraction=0.004; Pinteraction=0.0004; Pinteraction=0.0002; Pinteraction=0.07). For 
example, supplementing B vitamins resulted in a reduction in effect size by 58% for cg06194186,!
 62 
 
Table 2.2 The Houseman estimates of different leukocyte types in isolated 
CD4+ T helper cells  
Cell Type Median IQR Minimum Maximum 
!
Exposure 1 
CD4 T helper Cells (%) 96.92% 5.12% 81.85% 100.00% 
CD8 T Cells (%) 2.67% 3.74% 0.00% 5.92% 
B Cells (%) 0.30% 1.13% 0.00% 8.20% 
Granulocytes (%) 0.00% 0.20% 0.00% 4.65% 
Monocytes (%) 0.00% 0.00% 0.00% 0.00% 
Nature Killer Cells (%) 0.00% 0.00% 0.00% 4.68% 
     
!
Exposure 2 
CD4 T helper Cells (%) 94.84% 7.14% 81.03% 99.65% 
CD8 T Cells (%) 3.14% 2.46% 0.00% 6.01% 
B Cells (%) 0.75% 2.88% 0.00% 5.20% 
Granulocytes (%) 0.00% 0.87% 0.00% 4.90% 
Monocytes (%) 0.00% 0.00% 0.00% 0.00% 
Nature Killer Cells (%) 0.00% 0.00% 0.00% 7.65% 
     
!
Exposure 3 
CD4 T helper Cells (%) 96.09% 4.73% 85.10% 100.00% 
CD8 T Cells (%) 2.37% 4.04% 0.00% 5.77% 
B Cells (%) 0.42% 1.04% 0.00% 3.94% 
Granulocytes (%) 0.00% 0.21% 0.00% 6.14% 
Monocytes (%) 0.00% 0.00% 0.00% 0.00% 
Nature Killer Cells (%) 0.00% 0.00% 0.00% 3.11% 
IQR indicates inter-quartile range. 
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Table 2.3 Top ten loci associated with two-hour PM exposure and the effect modification by B vitamins supplement, 
selected by effect size  
Illumina CpG 
designation Genomic position 
Relation 
to CpG 
islands 
Gene 
symbol 
Change in 
DNAm ! P 
Effect 
modification by 
B vitamins P 
Positive association with PM2.5 exposure 
cg06194186 Chr 2: 207803693 
 
CPO 1.74 2.3E-05 -1.00 0.003 
cg07689821 Chr 6: 33290736 Island DAXX 1.72 1.3E-05 -0.84 0.01 
cg00068102 Chr 2: 121619261 
 
GLI2 1.67 4.9E-05 -1.22 0.0007 
cg00647528 Chr 18: 32957127 Island ZNF396 1.66 4.7E-05 -0.52 0.1 
cg15426626 Chr 12: 132984261† Island 
 
1.60 7.6E-06 -0.73 0.01 
        Negative association with PM2.5 exposure 
cg10719920 Chr 21: 46724843† S_Shelf 
 
-1.77 1.0E-06 0.49 0.07 
cg21986027 Chr 6: 169238138† 
  
-1.68 1.2E-05 1.27 0.0002 
cg17157498 Chr 19: 1383493 Island NDUFS7 -1.67 1.3E-05 1.24 0.0004 
cg08075528 Chr 19: 1961017 Island CSNK1G2 -1.63 5.8E-05 1.03 0.004 
cg26995744 Chr 2: 200322034 Island SATB2 -1.61 3.0E-05 1.14 0.001 
 SD indicates standard deviation; IQR indicates inter-quartile range. 
† Illumina array annotation indicates that these loci are not located within an annotated CpG region and are not 
associated with any gene.
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Figure 2.2 Volcano plot depicting the distribution of estimated effect of fine particle exposure on the epigenome 
 
Infinium 450K data were filtered for poor-performing samples and probs and normalized. Analyses were adjusted for season, 
chamber humidity and temperature. The vertical lines indicate suggestive threshold based on effect size, while the horizontal 
line reflects the suggestive threshold based on effect size and statistical significance (P values).
 65 
 
Figure 2.3 Quantile-Quantile plot for associations of fine particle exposure with epigenome-wide DNA methylation in circulating 
CD4+ T helper cells 
 
Lambda =1.03 
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49% for cg07689821, 73% for cg00068102, 31% for cg00647528, 45% for cg15426626, 28% 
for cg10719920, 75% for cg21986027, 74% for cg17157498, 63% for cg08075528, and 71% for 
cg26995744, respectively. 
 
The genomic position, relation to CpG islands, and gene symbol are listed in detail in Table 2.3. 
The top two loci that are associated with known genes (selected based on effect size of PM2.5) 
were cg06194186 and cg17157498. Locus cg06194186 is located in the promoter region 
(TSS1500) of CPO (Carboxypeptidase O) gene, and locus cg17157498 is located in the promoter 
region (TSS1500) of NDUFS7 (NADH Dehydrogenase (Ubiquinone) Fe-S Protein 7) gene.  
 
Effect of PM2.5 and B vitamins supplement on mitochondrial DNA content 
Because CPO!and NDUFS7 are both involved in mitochondrial oxidative metabolism,43, 44 we 
further tested the associations of PM2.5 with mitochondrial DNA content (mtDNA/nDNA ratio), 
as well as the potential role of B vitamins supplement on their relationship. Compared to medical 
air, two-hour exposure to PM2.5 was estimated to be nonsignificantly associated with an 1.14% 
(95%CI: -8.71%, 10.99%; P=0.82) change in mitochondrial DNA content. However, 24 hours 
after exposure, PM2.5 exposure was significantly associated with 8.11% (95%CI: 3.31%, 12.91%; 
P=0.002) lower mitochondrial DNA content, compared to medical air (Table 2.4). We did not 
observe significant effect of medical air on the mitochondrial DNA content (Table 2.4). B 
vitamins supplement did not seem to have direct effect on the mitochondrial DNA content; 
however, it significantly reduced the estimated effect of PM2.5 on the mitochondrial DNA 
content by 105% (Pinteraction=0.02), at 24-hour post exposure (Figure 2.4 and Table 2.4). With B 
vitamins supplement, two-hour PM2.5 exposure was no longer significantly associated with 
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mitochondrial DNA content (95%CI: -10.80%, 7.63; P=0.73) (Table 2.4) change in the. 
Likewise, B vitamins supplement nonsignificantly reduced the estimated effect of PM2.5 on the 
mitochondrial DNA content by 47% (Pinteraction=0.93), immediately post exposure (Figure 2.4 and 
Table 2.4). 
 
Sensitivity analysis 
We conducted permutation test to rule out that the observed top two loci were false-positive 
finding. We randomly paired the exposure and treatment status with methylation data within 
each subject and ran liner mixed models with random intercepts. We calculated the permutation 
P value testing being a false-positive finding (H0) based on the observed t statistic (t.actual) and 
the distribution of the t statistics obtained from 1000 permutation simulations (t.nulls).  When 
t.actual is greater than 0, the Ppermutation is defined as (number of t.nulls > t.actual + number of 
t.nulls < -t.actual)/1000. When t.actual is less than 0, the Ppermutation is (number of t.nulls < t.actual 
+ number of t.nulls > -t.actual)/1000. The Ppermutation was <0.0001 for both top loci.! 
 
Due to long biological half-life of body stores of B vitamins"45 the present study could not 
randomize on the order for placebo vs B vitamins supplement. This created potential 
confounding due to temporal trend. We minimized potential influence by time via adjusting for 
dates since entry, and this adjustment did not affect our conclusion (data not shown). In the 
analysis involving the mitochondrial DNA content, we additionally adjusted for age, body mass 
index, and race to examine if our results are sensitive to covariates specification. Our results 
were robust and consistent (data not shown).  
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Table 2.4 Effect of medical air, B vitamins, and two-hour exposure to fine particles (PM2.5) 
on mitochondrial DNA copy number, and the attenuated PM2.5 effect due to B Vitamins 
treatment 
!! % Change* P 95% CI 
  Post-exposure 
Effect of medical air -6.96 0.29 -20.00 to 6.08 
Effect of B vitamins -5.25 0.39 -17.42 to 6.93 
Effect of PM2.5, compared to medical air  1.14 0.82 -8.71 to 10.99 
PM2.5 Effect attenuation by B vitamins -0.54 0.93 -13.46 to 12.38 
! ! ! !
!
24-hour post-exposure 
Effect of medical air 2.23 0.24 -1.57 to 6.03 
Effect of B vitamins -4.25 0.43 -15.02 to 6.53 
Effect of PM2.5, compared to medical air  -8.11 0.002 -12.91 to -3.31 
PM2.5 effect attenuation by B vitamins 8.54 0.02 -1.17 to 15.92 
* Represents the % change in mitochondrial DNA copy number associated with PM2.5 
exposure. Results were adjusted for chamber humidity, chamber temperature, and season 
(Spring/Summer/Fall/Winter). 
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Figure 2.4 Percent change in mitochondrial DNA (mtDNA) copy number after each exposure experiment, compared to pre-exposure 
status 
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DISCUSSION AND CONCLUSION 
This study on a crossover intervention trial with controlled exposure experiments determined that 
two-hour exposure to concentrated ambient PM2.5 (250µ/m3) has substantial impact on the 
dynamic epigenetic landscape in circulating CD4+ Th cells among healthy adults. Our trial 
demonstrated that these effects can be counteracted with B vitamins supplement (i.e., folic acid, 
Vitamins B6 and B12). Furthermore – as the top loci suggested potential modulation of 
mitochondrial function – we validated this hypothesis by showing that PM2.5 significantly altered 
mitochondrial DNA content in circulating CD4+ Th cells, and B vitamins supplement nearly 
completely offset these effects.  
 
Air pollution has been consistently associated with adverse health outcomes in epidemiological 
studies. 46-49 In a recent study with 19 million participants for 10 follow-up years, the authors 
observed an 11% increase in mortality rate associated with each 10 !g/m3 elevation in annual 
PM2.5 concentrations.5 Although the biological mechanism underlying the health effects of PM2.5 
remains unclear, several biological pathways have been proposed, including systemic 
inflammation and oxidative stress.50-53 Observational studies have repeatedly shown that PM2.5 
disturbs human DNA methylation profiles,12-14, 18, 54, 55 which might acerbate the oxidative and 
inflammatory responses following exposure.!12, 57, 58 Previous human exposure study showed that 
the Toll-like Receptor 4 (TLR4) gene hypomethylation in leukocytes mediates a part of the effect 
of particulate air exposure on blood pressure elevation.56 However, its candidate-gene approach 
limited the capability to search for novel epigenetic markers that change upon PM2.5 exposure. 
Recently, an epigenome-wide association study (EWAS) examined the impact of low-
concentration air pollution on DNA methylation in whole blood.11 However, the interpretation of 
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their findings is limited due to potential bias due to cell-type distribution.17 Taken together, the 
present study – a cell-type-specific EWAS using controlled exposure experiments – has unique 
advantage to provide unbiased insight on the novel epigenetic underpinnings of the pro-
inflammatory and pro-oxidative effects of PM2.5.57  
 
In line with our hypothesis, the present study demonstrated the acute effects of PM2.5 inhalation 
on the methylation status in the promoter region of genes that are critical in mitochondrial 
function and oxidative metabolism:43, 44 CPO, a member of the metalloenzyme family,44 is 
involved in metal ion binding,  metallopeptidase, and metallocarboxypeptidase activities – which 
are essential in regulation of the steady-state concentration of O2" in the intermembrane space of 
mitochondria;58 NDUFS7 encodes one of the subunits of the mitochondrial respiratory chain 
complex I that transfers electrons from NADH to coenzyme Q, and NDUFS7 mutations were of 
etiological significance in mitochondrial complex I deficiency.59 Although mitochondria have 
their own genetic material distinct from the nuclear DNA, the majority of mitochondrial proteins 
are encoded by the nuclear genome.60, 61 The observation that PM2.5 substantially altered the 
methylation status of mitochondria-relevant nuclear genes indicates that mitochondria – the 
specialized organelles that regulate cellular-redox-balance and supplies energy – might be the 
immediate target of PM-induced cellular damage.62, 63  
 
Our results on mitochondrial DNA content supported the findings from epigenome-wide DNA 
methylation scan. Exposure to PM2.5 for two hours is followed with 8.11% (95%CI: 3.31%, 
12.91%; P=0.002) reduction in mitochondrial DNA content at 24-hour post exposure, compared 
to medical air (Table 2.4). Mitochondria, the cytoplasmic organelles that play a pivotal role in 
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cellular metabolic functions and energy production, are the main immediate target of PM-
induced oxidative stress.62-64 The cellular mitochondrial genomic content is stringently regulated 
by biogenesis/degradation machinery,65 which is vital in the determination of cell survival and 
function. To certain extent, intracellular reactive oxygen species (ROS) challenge can be 
buffered by compensatory mitochondria biogenesis – an adaptive stress response following 
environmental challenge to eliminate cellular oxidative damage.38, 39 However, persistent 
oxidative stress may eventually overwhelm the adaptive response system and lead to 
mitochondrial DNA depletion via mitophagy.38, 66 Our results support this hypothesis by 
demonstrating that exposure to high concentration PM2.5 can reduce the mitochondrial DNA 
consents in circulating CD4+ Th cells. Consistent with our results, a recent study reported that a 
10 !g/m# increase in coarse PM (PM10) exposure during pregnancy was associated with a 16.1% 
decrease in placental mitochondrial DNA content.67 The present study showed that PM2.5 
exposure altered the DNA methylation status of important mitochondria-related genes 
immediately post exposure, and subsequently reduced the mitochondrial DNA content at 24-hour 
post exposure. Although formal mediation analysis was not performed in the present study due to 
the lack of statistical power, our result suggests that short-term PM2.5 exposure depletes 
mitochondrial DNA content likely by modulating DNA methylation profile. These findings have 
paved the way for targeted epigenetic interventions.  
 
DNA methylation is a modifiable biochemical process relying on methyl-group supplying 
nutrients such as B vitamins, and higher B vitamins intakes is postulated to increase DNA 
methylation levels.10, 20, 21 This feature renders B vitamins supplement an attractive 
pharmaceutical intervention to counteract the effects of PM pollution, which has been associated 
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with loss of DNA methylation on inflammatory genes.56 Classic experiments on the Agouti Avy 
mice and other models have shown that dietary methyl nutrients, added during gestation20, 24 or 
later even in adult life,25-27 can be used to modulate DNA methylation status. In human studies, 
intake of a folic acid-depleted diet for several weeks led to hypomethylation of lymphocyte 
genomic DNA among post-menopausal women, and this hypomethylation was reversed when 
folic acid intake was subsequently increased.28 In addition, among patients with colorectal 
adenomatous polyps, folic acid supplementation led to a 31% increase in leukocyte DNA 
methylation and a 25% increase in DNA from the colonic mucosa.68 Potential for human 
translation is also demonstrated in in vivo studies, which showed that methyl-group supplying 
nutrients can be used to reverse the loss of DNA methylation induced by environmental 
pollutants.29, 69 However, whether B vitamins can be used to limit adverse effects from an 
environmental exposure has never been tested in human studies. For the first time, our research 
provided the experimental evidence showing that the epigenetic and oxidative effects of PM2.5 
can be curbed using four-week B vitamins supplement. Remarkably, in our data, B vitamins 
supplement not only curbed PM-induced hypomethylation, but also attenuated PM-induced 
hypermethylation. These findings suggest that B vitamins have beneficial effects on the 
epigenome that are not restricted to acting solely as methyl group supplying nutrients. Rather, B 
vitamins might be a dynamic regulator that can both up-regulate and down-regulate the 
methylation status.  
 
A major innovation of the present study over previous human epigenetics studies is the use of 
isolated CD4+ Th cells for epigenome-wide DNA methylation analysis. The Houseman cell 
proportion estimates indicated high purity of the analyzed samples, therefore the associations 
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observed between PM2.5 or B vitamins and DNA methylation is unlikely due to changes in 
leukocyte composition. Considering the crossover design of the present study, we arranged 
samples from the same volunteer on the same chip. We ensured that the exposure and treatment 
status of the volunteer are independent of the plating scheme by randomizing samples from the 
same study subjects across rows to minimize bias due to technical variables. The pre- and post-
exposure samples were plated on the same row to minimize row effect. Thus, the measurement 
error of DNA methylation can be assumed to be nondifferential and therefore likely to bias the 
results towards the null hypothesis. To rule out that our results reflect false-positive findings, we 
conducted permutation test, and further validated the EWAS results with a widely accepted 
mitochondrial marker – mitochondrial DNA content – with a highly reproducible RT-PCR 
method. The crossover design of the present study controlled for time invariant factors such as 
gender, race, body mass index, etc. In addition, all exposure experiments were conducted at the 
same time of the day to eliminate impact due to diurnal variation.  
 
We acknowledge several limitations in the present study. Our EWAS is underpowered to meet 
the Bonferroni threshold for significance with only 10 volunteers (30 exposure experiments). We 
selected the top loci based on both effect size and statistical significance, because those loci are 
more likely to infer biological significance. We could not randomize on the treatment (placebo vs 
B vitamins) order due to long biological half-life of body stores of B vitamins"45 which created 
potential confounding due to temporal trend or learning effect (i.e., the volunteers might be more 
tolerant with the PM effects at the second PM exposure). The short study duration with only 
four-week time intervals also reduced the impact of temporal trend. In the sensitivity analysis, 
we adjusted for the amount of time spent since the study entry, and our results were robust and 
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consistent. While residual confounding is possible, considering the magnitude of our effect 
estimates and the consistency of our findings, it is unlikely that the observed association 
reflected bias resulting from confounding.   
 
The unclear mechanistic underpinning of PM2.5’s health effects remains the major gap in current 
knowledge – therefore creating enormous challenges to develop preventative strategies. The 
present study is the first human intervention trial in the investigation of novel mechanistic 
pathway linking air pollution and adverse health effects, and potential targeted preventive 
approaches. We demonstrated that ambient PM2.5 exposure peak has unfavorable epigenetic and 
pro-oxidative effects, which, can be neutralized by B vitamins supplementation. Our findings 
suggest promising opportunities to aid the development of novel intervention strategies – which 
is particularly important for pathologies related to non-preventable exposures such as PM2.5 
pollution. Future trials with a larger sample size are warranted to shed light on the precise 
pathophysiological processes of PM-induced inflammatory and oxidative responses, as well as 
the mechanism underlying the protective effect of B vitamins. 
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 Chapter 3 
Cardiac Autonomic Dysfunction: Particulate Air Pollution Effects are Modulated by 
Epigenetic Immunoregulation of Toll-like Receptor 2 and Dietary Flavonoid Intake 
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Background: Short-term fine particles (PM2.5) exposure is associated with reduced heart rate 
variability (HRV), a strong predictor of cardiac mortality among older people. Identifying 
modifiable factors that confer susceptibility is essential for intervention. We evaluated whether 
Toll-like Receptor 2 (TLR2) methylation, a reversible immune-epigenetic process, and its dietary 
modulation by flavonoids and methyl nutrients, modify susceptibility to HRV effects following 
PM2.5 exposure.  
Methods and Results: We measured HRV and PM2.5 repeatedly over 11 years (1,275 total 
observations) among 573 elderly men from the Normative Aging Study. Blood TLR2 
methylation was analyzed using pyrosequencing. Daily flavonoid and methyl nutrients intakes 
were assessed through the Food Frequency Questionnaire. Every 10 !g/m3 increase in 48-hour 
PM2.5 moving average was associated with 7.74% (95%CI: -1.21%, 15.90%; P=0.09), 7.46% 
(95%CI: 0.99%, 13.50%; P=0.02), 14.18% (95%CI, 1.14%, 25.49%; P=0.03), and 12.94% 
(95%CI, -2.36%, 25.96%; P=0.09) reductions in root mean square of successive differences 
(rMSSD), standard deviation of normal-to-normal intervals (SDNN), low-frequency (LF) power, 
and high-frequency (HF) power, respectively. Higher TLR2 methylation exacerbated the rMSSD, 
SDNN, LF, and HF reductions associated with heightened PM2.5 (Pinteraction=0.006, 0.03, 0.05, 
0.04, respectively). Every interquartile-range increase in flavonoid intake was associated with 
5.09% reduction in mean TLR2 methylation (95%CI, 0.12%, 10.06%; P=0.05) and counteracted 
the effects of PM2.5 on LF (Pinteraction=0.05). No significant effect of methyl nutrients on TLR2 
methylation was observed.  
Conclusions: Higher TLR2 methylation may confer susceptibility to adverse cardiac autonomic 
effects of PM2.5 exposure in older individuals. Higher flavonoid intake may attenuate these 
effects, possibly by decreasing TLR2 methylation. 
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INTRODUCTION 
Particulate matter (PM) exposure contributes to an estimated 3.7 million annual deaths 
worldwide.1 According to the American Heart Association (AHA), PM exposure is a modifiable 
primary contributor to cardiovascular morbidity and mortality, often resulting from acute 
cardiovascular effects after short-term exposure peaks.2 The major sources of PM2.5 pollution are 
combustion activities (motor vehicles, power generation, and industrial processes), biomass 
burning, and other human activities such as heating and cooking.2 Because prevention of 
exposure to PM is particularly challenging—more than 80% of people in the United States (US) 
receive some exposure—it is essential to identify modifiable factors that contribute to individual 
susceptibility to cardiac effects to aid the development of effective interventions.  
 
Short-term PM exposure has been associated with reduced heart rate variability (HRV) through 
epidemiological studies.3,4 Impaired autonomic modulation of the rhythmic activity of the sinus 
node, as reflected in reduced HRV, represents a pathophysiologic mechanism by which air 
pollution may lead to cardiac mortality, especially among older individuals.5,6 Notably, HRV 
shows wide inter-individual variability, as well as highly variable responses to PM exposure.7 
Therefore, HRV is an ideal early surrogate marker of cardiovascular autonomic dysfunction for 
identifying underlying factors that may modify susceptibility to cardiovascular effects of PM 
exposure. Further, growing evidence indicates that systemic inflammation exacerbates HRV 
disturbances following PM exposure.8 PM with aerodynamic diameter < 2.5 micrometers (PM2.5) 
is especially deleterious because it penetrates into the alveoli and may act as a stimulus to trigger 
local cytokine production and systemic inflammation.9 Thus, immunoregulation is critical to 
limiting immune-mediated cardiovascular pathology.10  
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Molecules involved in immunoresponses are attractive as potential modulators of cardiovascular 
pathology following PM exposure. Toll-like receptors (TLRs), a group of receptors abundantly 
expressed on leukocytes, have emerged as crucial first-responders linking innate and adaptive 
immunity after environmental challenge.11 TLR2, in particular, is a unique TLR family member 
that not only assists the clearance of bacterial components contained in PM via pathogen 
recognition,12 but also modulates the expansion and behavior of regulatory T cells (Tregs)—the 
dominant circulating regulator of immunosuppression.13,14 TLR2-related immunity is controlled 
through epigenetic mechanisms: increased methylation in the TLR2 promoter region is usually 
associated with TLR2 silencing, while decreased methylation permits TLR2 expression.15 
Therefore, maintaining a proper methylation level of the TLR2 gene is critical to ensure 
protective immunity.  
 
Importantly, DNA methylation is reversible, thereby providing unique opportunities for 
modulation. This feature is critical, particularly for pathologies related to non-preventable 
exposures, as it can offer potential interventions to ameliorate exposure-related disease. Nutrients 
such as flavonoids and methyl nutrients can modify gene-specific methylation in opposite 
directions.16 Flavonoids, the most common group of polyphenolic compounds in the human diet, 
can lower DNA methylation by reducing DNA methyltransferase activity.17,18 Methyl nutrients 
such as folic acid, vitamin B12, and methionine, on the other hand, may increase methylation by 
providing methyl donors.19 Thus, determining how such nutrients alter methylation states can 
provide insight that may be used to counteract exposure effects. 
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No study has yet investigated whether DNA methylation and nutrient intake may modify the 
cardiovascular effects of air pollution exposure. In this study, we hypothesized that programming 
of TLR2 inactivation by increased methylation contributes to “epigenetic susceptibility” for 
immune-mediated PM-induced cardiovascular responses, as reflected in steeper reductions in 
HRV following short-term PM2.5 exposure. We utilized the Normative Aging Study, a cohort of 
aging men in Eastern Massachusetts, to investigate the relationship between short-term PM2.5 (48 
hours) exposure and HRV, and to examine whether TLR2 methylation in blood leukocytes 
modifies this relationship. We also examined the effect of flavonoid and methyl nutrients (folic 
acid, vitamin B12, and methionine) intakes on TLR2 methylation and explored their role as 
modifiers of the short-term effects of ambient PM2.5 exposure on HRV. In addition to our 
primary hypothesis, we examined the effect of black carbon, carbon monoxide, nitrogen dioxide, 
and ozone on HRV, as well as the relationship between TLR2 methylation and plasma 
inflammatory markers including interleukin 6 (IL6), IL8, IL1$, tumor necrosis factor alpha 
(TNF%), TNF&, C-reactive protein (CRP), intercellular adhesion molecule 1 (ICAM-1), and 
vascular endothelial growth factor (VEGF).  
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METHODS 
Study Population 
The Normative Aging Study (NAS) is an ongoing prospective cohort of older male participants 
established in Eastern Massachusetts by the U.S. Veterans Administration (VA).20 For the 
present study, we excluded participants with incomplete data on PM2.5 exposure and HRV, 
leaving a total of 573 participants who were community-dwelling men free of heart arrhythmias 
at examination (Figure 3.1). Participants were recalled for visits every three to five years and we 
considered visits conducted since November 2000 (i.e., the earliest date for which PM2.5 data 
were available) through 2011, for a total of 1,275 visits (one visit to four visits per participant; 
average 2.2 visits). Among the 573 participants, 500 participants had methylation data, 513 
participants had flavonoid intake data, and 482 participants had methyl nutrients intake data. The 
study was approved by the institutional review boards of all participating institutions. All 
subjects provided informed consent.   
 
HRV Measurement 
HRV was measured in the morning for seven minutes with a 2-channel electrocardiography 
(ECG) monitor, and time-domain variability and frequency-domain variability of the heart rate 
were obtained as described previously.3 Observations with HRV measurement time < 3.5 min 
were excluded. The root mean square of successive differences (rMSSD) and standard deviation 
of normal-to-normal intervals (SDNN) were measured representing the time domain.21 Low-
frequency (LF) (0.04-0.15 Hz) and high-frequency (HF) (0.15-0.4 Hz) power were used to 
represent the frequency domain.21  
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Blood TLR2 Methylation and Plasma Inflammatory Markers 
TLR2 methylation was analyzed on blood samples, collected after overnight fasting, at five CpG 
positions within the promoter region (Figure 3.2) using bisulfite-treated pyrosequencing, as 
described previously.22 Exact positions and pyrosequencing primers were reported previously.20 
The degree of methylation is reported as the ratio of methylated cytosines over the sum of 
methylated and unmethylated cytosines (%5mC). Plasma inflammatory markers including IL6, 
IL8, IL1$, TNF%, TNF&, CRP, ICAM-1, and VEGF were measured using previously described 
methods.20,22,23 
 
Air Pollution and Weather Data 
PM2.5 exposure levels across the study area were estimated based on a validated hybrid spatio-
temporal prediction model,24 which was used in previous epidemiological studies.25,26 This 
exposure assessment method combined real physical measurements from the MODIS (Moderate 
Resolution Imaging Spectroradiometer) satellite-derived aerosol optical depth (AOD) and classic 
land-use regression methods to predict daily PM2.5 concentration levels across the Boston area 
from 2000 to 2011, at a 10 ' 10 km spatial resolution. Kloog and coauthors demonstrated that 
this method provides more accurate spatial resolution and unbiased predictions compared to prior 
models27 without compromising temporal resolution.28 For more methodological details of the 
prediction model please refer to Kloog et al.28,29 The 48-hour PM2.5 moving averages before each 
examination were assigned based on the participants’ home addresses. The 48-hour moving 
averages of outdoor apparent temperature was tabulated based on outdoor air temperature, 
relative humidity, and wind speed, which were obtained from the Boston airport weather station. 
Black carbon concentration was measured at the Harvard School of Public Health monitoring 
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site, 1 km from the exam site, using an aethalometer (Magee Scientific, Berkeley, CA).30 Carbon 
monoxide, nitrogen dioxide, and ozone were obtained from the Massachusetts Department of 
Environmental Protection local monitoring sites, using previously descripted method.30 
 
Food Frequency Questionnaire and Nutrient Intake  
At every visit, detailed information on the typical daily dietary intake of food and beverage items 
over the previous year was assessed with a self-administered validated semi-quantitative Food 
Frequency Questionnaire (FFQ) adapted from the questionnaire used in the Nurses’ Health Study. 
Details on the reproducibility and validity of this FFQ for estimating daily nutrient intakes,31"32 
including flavonoid33 and methyl nutrients (folic acid, vitamin B12, and methionine) intake21 
were published elsewhere. To estimate flavonoid intakes, we constructed a database for 
assessment of intake of the different flavonoid subclasses using the updated and expanded U.S. 
Department of Agriculture (USDA) flavonoid content of foods and the proanthocyanidin 
databases together with other sources.34,35 Intakes of individual compounds were calculated as 
the sum of the consumption frequency of each food multiplied by the content of the specific 
flavonoid for the specified portion size. For foods in the FFQ for which there were no values 
available in the USDA database, we searched a European database (EuroFIR eBASIS; 
http://www.eurofir.org) and other sources to ensure all available high-quality data on flavonoid 
values could be included in the database. However, although these other sources served as a 
validation to the USDA database, the addition of the EuroFIR data and the published literature 
did not contribute to more than 5–10% of the overall data used in the calculation of intakes for 
this analysis. For each participant and visit in this analysis, we derived average daily intakes 
(mg/day) at each visit of the subclasses commonly consumed in the U.S. diet. The specific 
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subclasses included anthocyanins (cyanidin, delphinidin, malvidin, pelargonidin, petunidin, 
peonidin), flavanones (eriodictyol, hesperetin, naringenin), flavan-3-ols (catechins, 
gallocatechins, epicatachin, epigallocatechin, epicatachin-3-gallate, epigallocatechin-3-gallate), 
flavonols (quercetin, kaempferol, myricetin, isohamnetin), flavones (luteolin, apigenin), and 
polymers (including proanthocyanidins excluding monomers, theaflavins, and thearubigins). The 
measure “total flavonoids” represented the sum of these six subclasses. Assessment of daily 
dietary folic acid intake was based on the frequency and dosage information from the FFQ. The 
average daily total fruit and total vegetable intake (servings/day) was also measured based on 
FFQ, over the past year. The estimates were made using software developed by the Nurses’ 
Health Study at the Channing Laboratories and processed by Channing Laboratories operators. 
To avoid undue influence of outliers, we excluded all the questionnaires reporting <500 or >4200 
total calories per day. We also truncated flavonoid and folic acid intakes at median ± 
3'(interquartile-range). Fewer than 0.5% of observations were excluded. 
 
Statistical Methods  
Confounding Selection and Model Assumption 
For the analysis involving PM2.5 exposure, TLR2 methylation, and HRV, we adjusted for 
potential confounders, selected based on literature evidence, i.e., age, room temperature, outdoor 
apparent temperature, season (winter/spring-fall/summer), household income, weekday of the 
visit, and the visit date. To increase efficiency, we also adjusted for the following risk factors for 
decreased HRV: body mass index (BMI), smoking status (never/former/current), physical 
activity, fasting glucose, alcohol consumption (< 2 drinks/day/( 2 drinks/day), hypertension, and 
use of calcium channel blockers, $-blockers, and angiotensin-converting enzyme inhibitors. For 
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the analysis examining flavonoid and methyl nutrients intake as effect modifier(s) for the 
association between PM2.5 exposure and HRV, we adjusted for all the covariates listed above, as 
well as for total fiber, vitamin C, and caloric intakes. To examine the effect of flavonoid and 
methyl nutrients intakes on TLR2 methylation, we adjusted for age, BMI, smoking status, total 
fiber, vitamin C, caloric intake, household income, and physical activity.  
HR, rMSSD, SDNN, LF, and HF were log10-transformed to improve normality and stabilize the 
variance. All independent variables were fitted as time-varying covariates. Non-linear 
relationships were characterized first using graphical analyses between HRV and all the 
covariates, as well as between nutrient intakes and TLR2 methylation. When the graphical 
analyses suggested non-linear association, higher order terms (quadratic, cubic, etc.,) were 
considered in the model, and a likelihood ratio test was used to determine the number of higher 
order terms needed. In the present study, nonlinearity between apparent temperature and HRV 
was accounted for by the use of linear and quadratic terms. In addition, we utilized the likelihood 
ratio test to determine whether it is adequate to model the effect modifiers with a linear trend. 
Additional analysis using spline regression models were also used to confirm linearity.    
 
To account for repeated assessments for many participants, all statistical models were linear 
mixed effect models with a random intercept assigned to each subject, which used compound 
symmetry covariance structure. A compound symmetry covariance structure was decided upon 
after comparing the Akaike information criterion (AIC) among models with different covariance 
structures as well as assessing the fit of the compound symmetry covariance structure to our data 
by examining the estimated residual covariance matrix. An analysis using a robust/sandwich 
estimator for the variance gave very similar results and thus analysis without use of 
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robust/sandwich variance estimators were reported in the manuscript. To examine whether any 
position in the TLR2 promoter region modified the association between PM2.5 exposure and HRV, 
we fitted a single linear mixed effect model with five interaction terms included in the model, 
which are the interactions between each of the five TLR2 positions and PM2.5 (in addition to their 
respective main effects and other covariates) (Model 1). To test the null hypothesis that none of 
the positions modified the association between PM2.5 exposure and HRV (H0: &1 = &2 = ... = &5 = 
0), the coefficients of these five interaction terms were tested all together using a single Wald 
test, whose null distribution is approximated using a F-distribution (global test). 
Yij = $0 + $1PM2.5ij + $2X2ij + … + $pXpij + %1TLR21ij + … + %5TLR25ij + &1PM2.5ij*TLR21ij + … + 
&5PM2.5*TLR25ij + bi + )ij      (Model 1) 
As a secondary analysis, we also examined the effect modification by position-specific TLR2 
methylation by including an interaction term between position-specific TLR2 methylation and 
PM2.5 in the model (Model 2), only if the global test was significant. 
Yij = $0 + $1PM2.5ij + $2X2ij + … + $pXpij + %1TLR2kij + &1PM2.5*TLR2kij + bi + )ij      (Model 2) 
where Yij was the log10 of HRV measures for participant i at visit j, !0 was the overall 
intercept, bi was the separate random intercept for subject i, and bi ~ N(0, *),)ij ~ N(0, 
+2). TLR2kij was the TLR2 methylation level at the kth position (k=1-5) within the promoter 
region, for participant i at visit j. X2ij–Xpij were the covariates including confounders and 
predictors for HRV, for participant i at visit j. 
 
To describe the effect modification by potential effect modifiers, we estimated from the mixed 
effect models the HRV-PM2.5 associations at the values corresponding to the quartiles of each 
effect modifier and reported them separately. We reported effect estimates, 95% confidence 
 97 
 
!
intervals, and P values for the HRV-PM2.5 associations from the linear mixed effect models (i.e. 
% change in HRV per 10!g/m3 increase in PM2.5) for the midpoint of each quartile. Analyses 
were performed using SAS 9.4 (SAS Institute, Cary NC).  
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RESULTS 
Cohort Characteristics and Exposure Levels 
The NAS is a cohort of aging individuals, between 55 and 100 years old at the first visit of the 
present study (Figure 3.1). We excluded N=91 participants with heart arrhythmias at baseline. 
An additional N=63 participants were excluded as they had missing outcome (N=13 with 
missing HRV) or missing exposure (N=50 with missing PM2.5 exposure), giving a total of N=573. 
The baseline characteristics of the participants included in the final analysis are given in Table 1. 
All participants were male, and 96% were white. Seventy-nine percent of the participants were 
overweight, 19% were diabetics, and 71% were hypertensive. The study population included 5% 
current smokers and 19% heavy alcohol drinkers (( 2 drinks/day). During the study period 
(November 2000-December 2011), the 48-hour PM2.5 moving average varied between 2.14 
!g/m3 to 42.8 !g/m3 with an average exposure level of 10.5 !g/m3, which is lower than the U.S. 
Environmental Protection Agency’s daily health National Ambient Air Quality Standard for 
PM2.5 (35.0 !g/m3). The baseline mean methylation level across five CpG positions (Figure 3.2) 
in the TLR2 promoter region ranged between 0.3 %5mC and 7.1 %5mC. There was no apparent 
difference in exposure level or methylation level across different characteristic subgroups (Table 
3.1).   
 
Main Effect of Air Pollutants on HRV 
Average PM2.5 exposure over the 48 hours before the day of each visit was associated with 
significantly lowered SDNN and LF, marginally lowered rMSSD and HF, and non-significantly 
increased HR. Every 10 !g/m3 increase in the 48-hour PM2.5 moving average was associated 
with 7.74% (95% CI, -1.21%, 15.90%; P=0.09), 7.46% (95% CI, 0.99%, 13.50%; P=0.02), 
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Figure 3.1. The study participants in the Normative Aging Study, 2000-2011 
PM2.5 indicates particulate matter with aerodynamic diameter < 2.5 micrometers 
*In each analysis, some additional participants may have been excluded due to missing key study variables. We have noted in each 
table the corresponding sample size. 
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Figure 3.2. Schematic view of the genomic structure and CpG dinucleotides selected for analysis in the Toll-like Receptor 2 (TLR2) 
gene 
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The chromosomal location of the PCR amplicon for the TLR2 gene pyrosequencing assay is based on the Human Genome Assembly 
2009 (GRC37/hg19) (UCSC Genome Browser). The CpG island, gene promoter region, PSQ CpG sites, PCR primer, and PSQ 
sequence primer location are shown in the figure. TSS indicates the transcription start site. Position 1: CpG154605258; Position 2: 
CpG154605262; Position 3: CpG154605264; Position 4: CpG154605272; Position 5: CpG154605276 
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Table 3.1. Baseline characteristics of study participants (N=573), 48-hour moving average of particulate 
matter with aerodynamic diameter < 2.5 micrometers (PM2.5), and averaged methylation across CpG 
positions in the promoter region of Toll-like Receptor 2 gene 
Characteristics N (%) 
PM2.5 (!g/m3) 
TLR2 methylation 
(%5mC) 
mean (SD) mean (SD) 
Age (years)    
55-69 176 (30.7) 11.4 (5.2) 2.9 (1.3) 
70-79 293 (51.1) 11.7 (6.4) 3.1 (1.3) 
80-89 97 (16.9) 10.6 (6.1) 2.9 (1.1) 
> 90 7 (1.2) 13.0 (5.0) 3.4 (1.0) 
Physical activity (MET-hr/week)     
< 12 371 (64.8) 11.4 (6.3) 2.93 (1.2) 
12 to < 30 114 (19.9) 11.3 (5.3)  3.14 (1.4) 
" 30 88 (15.4) 11.7 (5.5) 3.08 (1.2) 
Alcohol (drinks/day)       
" 2 106 (18.5) 11.6 (6.7) 2.9 (1.1) 
< 2 467 (81.5) 11.4 (5.8)  3.0 (1.2) 
Diabetes       
Yes 111 (19.4) 11.0 (6.0) 2.9 (1.0) 
No 462 (80.6) 11.5 (6.0) 3.0 (1.3) 
Race       
White  549 (95.8) 11.4 (5.9) 3.0 (1.3) 
Non-white  24 (4.2) 11.6 (7.7) 2.8 (0.9) 
Hypertension       
Yes 405 (70.7) 11.3 (6.0) 3.0 (1.3) 
No 168 (29.3) 11.8 (6.0)  2.9 (1.2) 
BMI (kg/m2)       
< 25 123 (21.5) 12.4 (6.8) 3.0 (1.2) 
" 25 450 (78.5) 11.2 (5.7) 3.0 (1.3) 
Smoking       
Never 166 (29.0) 11.7 (6.0) 3.1 (1.4) 
Current 26 (4.5) 10.9 (3.8) 3.3 (1.1) 
Former 381 (66.5) 11.4 (6.1) 2.9 (1.2) 
Annual Income > $60,000       
Yes 272 (47.5) 11.0 (5.4) 3.1 (1.3) 
No 301 (52.5) 11.8 (6.5) 2.9 (1.2) 
MET indicates metabolic equivalent of task; BMI indicates body mass index 
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14.18% (95% CI, 1.14%, 25.49%; P=0.03), and 12.94% (95% CI, -2.36%, 25.96%; P=0.09) 
reductions in rMSSD, SDNN, LF, and HF, respectively (Table 3.2). Exposure to black carbon, 
carbon monoxide, nitrogen dioxide, and ozone over the 48 hours before the day of each visit 
were not significantly associated with HR, rMSSD, SDNN, LF, and HF (Table 3.3). 
 
Modification of PM2.5 Effect on HRV by TLR2 Methylation 
The effect of 48-hour PM2.5 exposure at participants’ homes on rMSSD, SDNN, LF, and HF was 
significantly modified by the level of methylation within the TLR2 promoter region (P=0.006 for 
rMSSD; P=0.03 for SDNN; P=0.05 for LF, and P=0.04 for HF, global test for interaction across 
five positions) (Table 3.4). PM2.5 exposure had no significant effect on HRV in individuals with 
low TLR2 methylation, but it showed increasingly negative effects on HRV as TLR2 methylation 
increased (Figure 3.3). For instance, in individuals with TLR2 methylation within the first 
quartile, every 10 !g/m3 increase in 48-hour PM2.5 exposure was associated with 8.77% (95% CI, 
-7.55%, 27.95%; P=0.31), -0.39% (95% CI, -11.76%, 12.45%; P=0.95), -7.25% (95% CI, -
27.74%, 19.06%; P=0.56), and 10.06% (95% CI, -16.25%, 44.64%; P=0.49) non-significant 
estimated changes in rMSSD, SDNN, LF, and HF, respectively (effects estimated at the mid-
point of the 1st quartile, i.e., 1.5 %5mC to represent the within-quartile effect, see Table 3.4); on 
the other hand, in the fourth TLR2 methylation quartile, every 10 !g/m3 increase in 48-hour 
PM2.5 exposure was associated with 26.38% (95% CI, 13.69%, 37.20%; P=0.0002), 13.94% 
(95% CI, 3.12%, 23.55%; P=0.01), 21.40% (95% CI, -0.39%, 38.47%; P=0.05), and 34.28% 
(95% CI, 13.84%, 49.87%; P=0.003) reductions in rMSSD, SDNN, LF, and HF, respectively 
(effects estimated at the mid-point of the 4th quartile, i.e., 4.4 %5mC to represent the within-
quartile effect). Analysis of individual position-specific methylation showed notable effect 
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Table 3.2. Effect of 48-hour moving average of particulate matter with aerodynamic 
diameter < 2.5 micrometers (PM2.5) on heart rate variability (HRV), Normative Aging 
Study, 2000-2011 (N=500) 
  Change in HRV per 10 !g/m3 increase in PM2.5 concentration* 
HRV measure % Change 95% CI P 
HR 0.42 -0.94 to 1.80 0.55 
rMSSD -7.74 -15.90 to 1.21 0.09 
SDNN -7.46 -13.50 to -0.99 0.02 
LF -14.18 -25.49 to -1.14 0.03 
HF -12.94 -25.96 to 2.36 0.09 
HR indicates heart rate; rMSSD indicates the root mean square of successive 
differences; SDNN indicates the standard deviation of normal-to-normal intervals; LF 
indicates low-frequency power (0.04–0.15 Hz); HF indicates high-frequency power 
(0.15–0.4 Hz); CI indicates confidence interval. 
*Results were adjusted for age; body mass index; fasting glucose level; 
hypertension; smoking status; alcohol consumption; physical exercise; household 
income; the use of calcium channel blocker, #-blocker, and angiotensin-converting 
enzyme inhibitor; room temperature; outdoor apparent temperature; season; weekday; 
and visit date. 
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Table 3.3. Effect of 48-hour moving average of black carbon, carbon monoxide, nitrogen dioxide, and ozone on heart rate variability (HRV), 
Normative Aging Study, 2000-2011 (N=573) 
 
  Black Carbon   Carbon Monoxide    Nitrogen Dioxide    Ozone  
HRV % Change*  95% CI P   
% 
Change* 95% CI P   
% 
Change* 95% CI P   
% 
Change* 95% CI P 
HR 0.04 -0.82 to 0.92 0.92  -0.97 
-3.16 to 
1.28 0.40  0.25 
-0.76 to 
1.27 0.63  -0.92 
-2.19 to 
0.37 0.16 
rMSSD -2.02 -7.59 to 3.88 0.49  -1.86 
-15.63 to 
14.15 0.81  -3.71 
-10.08 to 
3.11 0.28  -5.31 
-13.2 to 
3.3 0.22 
SDNN -2.28 -6.36 to 1.98 0.29  -2.19 
-12.42 to 
9.23 0.69  -1.93 
-6.72 to 
3.1 0.44  -4.13 
-10.04 to 
2.17 0.19 
LF -2.46 -10.82 to 6.68 0.59  -1.61 
-21.91 to 
23.96 0.89  -1.55 
-11.31 to 
9.3 0.77  -5.92 
-17.66 to 
7.5 0.37 
HF -1.91 -11.45 to 8.67 0.71   -2.55 
-25.13 to 
26.86 0.85   -7.29 
-17.7 to 
4.44 0.21   -5.19 
-18.57 to 
10.39 0.49 
HR indicates heart rate; rMSSD indicates the root mean square of successive differences; SDNN indicates the standard deviation of normal-
to-normal intervals; LF indicates low-frequency power (0.04–0.15 Hz); HF indicates high-frequency power (0.15–0.4 Hz); CI indicates 
confidence interval. 
*Results were adjusted for age; body mass index; fasting glucose level; hypertension; smoking status; alcohol consumption; physical 
exercise; household income; the use of calcium channel blocker, !-blocker, and angiotensin-converting enzyme inhibitor; room temperature; 
outdoor apparent temperature; season; weekday; and visit date. 
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Table 3.4. The effect of particulate matter with aerodynamic diameter < 2.5 micrometers 
(PM2.5) exposure on heart rate variability (HRV) at different mean Toll-like Receptor 2 
(TLR2) methylation levels, Normative Aging Study, 2000-2011 (N=500) 
  HR 
Mean TLR2 Methylation  % Change* 95% CI P 
Midpoint of Q1 (1.5 5mc%) -0.56 -2.88 to 1.82 0.64 
Midpoint of Q2 (2.2 5mc%) -0.10 -1.99 to 1.81 0.92 
Midpoint of Q3 (3.0 5mc%) 0.42 -1.25 to 2.11 0.62 
Midpoint of Q4 (4.4 5mc%) 1.34 -0.92 to 3.66 0.25 
Pglobal for Interaction†   0.62 
  rMSSD 
Mean TLR2 Methylation  % Change* 95% CI P 
Midpoint of Q1 (1.5 5mc%) 8.77 -7.55 to 27.95 0.31 
Midpoint of Q2 (2.2 5mc%) -1.01 -13.14 to 12.81 0.88 
Midpoint of Q3 (3.0 5mc%) -11.11 -20.87 to -0.16 0.05 
Midpoint of Q4 (4.4 5mc%) -26.38 -37.20 to -13.69 0.0002 
Pglobal for Interaction†     0.006 
!
SDNN 
Mean TLR2 Methylation  % Change* 95% CI P 
Midpoint of Q1 (1.5 5mc%) -0.39 -11.76 to 12.45 0.95 
Midpoint of Q2 (2.2 5mc%) -3.85 -12.78 to 6.00 0.43 
Midpoint of Q3 (3.0 5mc%) -7.65 -15.31 to 0.71 0.07 
Midpoint of Q4 (4.4 5mc%) -13.94 -23.55 to -3.12 0.01 
Pglobal for Interaction†     0.03 
 
LF 
Mean TLR2 Methylation  % Change* 95% CI P 
Midpoint of Q1 (1.5 5mc%) -7.25 -27.74 to 19.06 0.56 
Midpoint of Q2 (2.2 5mc%) -10.88 -27.11 to 8.96 0.26 
Midpoint of Q3 (3.0 5mc%) -14.86 -28.80 to 1.81 0.08 
Midpoint of Q4 (4.4 5mc%) -21.40 -38.47 to 0.39 0.05 
Pglobal for Interaction†     0.05 
!
HF 
Mean TLR2 Methylation  % Change* 95% CI P 
Midpoint of Q1 (1.5 5mc%) 10.06 -16.25 to 44.64 0.49 
Midpoint of Q2 (2.2 5mc%) -2.82 -22.02 to 21.10 0.80 
Midpoint of Q3 (3.0 5mc%) -15.71 -30.75 to 2.60 0.09 
Midpoint of Q4 (4.4 5mc%) -34.28 -49.87 to -13.84 0.003 
Pglobal for Interaction†     0.04 
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HR indicates heart rate; rMSSD indicates the root mean square of successive differences; 
SDNN indicates the standard deviation of normal-to-normal intervals; LF indicates low-
frequency power (0.04 –0.15 Hz); HF indicates high-frequency power (0.15–0.4 Hz); CI 
indicates confidence interval; Q1, Q2, Q3, and Q4 indicate the 1st, 2nd, 3rd, and 4th quartile. 
Results were adjusted for age; body mass index; fasting glucose level; hypertension; 
smoking status; alcohol consumption; physical exercise; household income; the use of 
calcium channel blocker, !-blocker, and angiotensin-converting enzyme inhibitor; room 
temperature; outdoor apparent temperature; season; weekday; and visit date. 
*The percent change in HRV per 10 "g/m3 increase in PM2.5 concentration. 
†Based on a global test for effect modification by position-specific methylation. 
Interaction terms between each of the five TLR2 positions and PM2.5 were included in the 
model, and these five interaction terms were tested jointly for effect modification using a 
Wald test (global test). 
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Figure 3.3. The effect of particulate matter with aerodynamic diameter < 2.5 micrometers (PM2.5) exposure on heart rate variability 
(HRV) at different mean Toll-like Receptor 2 (TLR2) methylation levels, Normative Aging Study, 2000-2011 (N=500) 
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log10HR indicates log10-transformed heart rate; log10rMSSD indicates log10-transformed root mean square of the successive 
differences; log10SDNN indicates log10-transformed standard deviation of normal-to-normal intervals; log10LF indicates log10-
transformed low-frequency power (0.04 –0.15 Hz); log10HF indicates log10-transformed high-frequency power (0.15–0.4 Hz); Q1, Q2, 
Q3, and Q4 indicate the 1st, 2nd, 3rd, and 4th quartiles.  
The association of PM2.5 with rMSSD, SDNN, LF, and HF is modified by mean TLR2 methylation levels, as indicated by the different 
slopes. The four lines in each figure represent the relationship between PM2.5 and HRV when the mean TLR2 methylation level is at 
the midpoints of each quartile. If there was no effect modification, the four lines would be the same. The Pglobal for Interaction was 
based on a global test for effect modification by position-specific methylation. Interaction terms between each of the five TLR2 
positions and PM2.5 were included in the model, and these five interaction terms were tested jointly for effect modification using a 
Wald test (global test). Results were adjusted for age; body mass index; fasting glucose level; hypertension; smoking status; alcohol 
consumption; physical exercise, household income; the use of calcium channel blocker, !-blocker, and angiotensin-converting enzyme 
inhibitor; room temperature; outdoor apparent temperature; season; weekday; and visit date. 
 110 
 
!
heterogeneity across the five CpG positions, with stronger effect modifications by positions 1, 3, 
and 5 (Table 3.5). 
 
Association of Flavonoid and Methyl Nutrients Intakes with TLR2 methylation 
The average daily flavonoid intake over the preceding year was negatively associated with mean 
TLR2 methylation, considered as the average methylation level across five CpG positions (5.09% 
reduction; 95% CI, 0.12%, 10.06%; per an interquartile-range increase in flavonoid intake; 
P=0.05) (Figure 3.4). In position-specific analyses (Figure 3.4 and Table 3.6), methylation at 
TLR2 promoter positions 1 and 4 showed the strongest associations with flavonoid intake.  We 
did not observe significant association between methyl nutrients (folic acid, vitamin B12, and 
methionine) intakes in the previous year and either mean or position-specific TLR2 methylation 
(Figure 3.4 and Figure 3.5).  
 
Effect Modification by Flavonoid and Methyl Nutrients intakes 
Higher average daily flavonoid intake over the preceding year significantly weakened the 
association between PM2.5 exposure and LF reduction (P=0.05), and produced a non-significant 
attenuation of the effect of PM2.5 exposure on rMSSD, SDNN and HF (P=0.79 for rMSSD; 
P=0.37 for SDNN; P=0.28 for HF) (Table 3.7 and Figure 3.6). PM2.5 exposure had no significant 
effect on LF in individuals with high flavonoid intake, but it was associated with increasingly 
negative effects on LF as flavonoid intakes decreased (Figure 3.6). In particular, in individuals at 
the first quartile of flavonoid intake, every 10 !g/m3 increase in 48-hour PM2.5 exposure was 
associated with a 16.48% (95% CI, -1.61%, 31.35%; P=0.07) reduction in LF (effects estimated 
at the mid-point of the 1st quartile, i.e., 128 mg/d to represent the within-quartile effect), while no  
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Table 3.5. Effect modification by position-specific Toll-like Receptor 2 (TLR2) methylation on the association between particulate matter with 
aerodynamic diameter < 2.5 micrometers (PM2.5) exposure and heart rate variability (HRV) (N=500)  
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    HR   rMSSD   SDNN 
Position Methylation % Change* 95% CI P   
% 
Change* 95% CI P   
% 
Change* 95% CI P 
1 
Midpoint of Q1 0.36 -1.96 to 2.75 0.76 ! 7.26 -8.65 to 25.94 0.39 ! 1.66 -9.79 to 14.56 0.79 
Midpoint of Q2 0.42 -1.38 to 2.24 0.65 ! -4.56 -15.66 to 8.01 0.46 ! -4.30 -12.71 to 4.93 0.35 
Midpoint of Q3 0.46 -1.22 to 2.17 0.60 ! -13.25 -22.84 to -2.47 0.02 ! -8.91 -16.51 to -0.63 0.04 
Midpoint of Q4 0.53 -1.72 to 2.83 0.65 ! -26.01 -36.84 to -13.31 0.0002 ! -16.11 -25.42 to -5.64 0.004 
P for Interaction†   0.92    0.0009    0.02              
2 
Midpoint of Q1 0.08 -2.12 to 2.34 0.94 ! -0.21 -14.47 to 16.43 0.98 ! -7.00 -17.08 to 4.3 0.22 
Midpoint of Q2 0.28 -1.49 to 2.09 0.76 ! -6.61 -17.49 to 5.72 0.28 ! -7.36 -15.51 to 1.58 0.10 
Midpoint of Q3 0.44 -1.23 to 2.13 0.61 ! -11.33 -21.1 to -0.35 0.04 ! -7.64 -15.31 to 0.73 0.07 
Midpoint of Q4 0.75 -1.4 to 2.95 0.50 ! -20.06 -31.31 to -6.98 0.004 ! -8.20 -17.98 to 2.74 0.14 
P for Interaction†   0.65    0.03    0.86              
3 
Midpoint of Q1 -0.82 -3.19 to 1.61 0.51 ! 5.96 -10.3 to 25.17 0.50 ! 1.15 -10.63 to 14.49 0.86 
Midpoint of Q2 -0.16 -1.99 to 1.71 0.86 ! -3.69 -15.24 to 9.44 0.56 ! -3.72 -12.44 to 5.87 0.43 
Midpoint of Q3 0.37 -1.3 to 2.07 0.67 ! -10.77 -20.6 to 0.28 0.06 ! -7.44 -15.13 to 0.94 0.08 
Midpoint of Q4 1.27 -0.85 to 3.44 0.24 ! -21.64 -32.48 to -9.05 0.00 ! -13.45 -22.51 to -3.33 0.01 
P for Interaction†   0.18    0.005    0.05 
             
4 
Midpoint of Q1 -0.28 -2.62 to 2.12 0.82 ! 2.48 -12.89 to 20.56 0.77 ! -4.43 -15.3 to 7.83 0.46 
Midpoint of Q2 0.11 -1.73 to 1.99 0.90 ! -4.88 -16.33 to 8.13 0.44 ! -6.13 -14.66 to 3.25 0.19 
Midpoint of Q3 0.45 -1.22 to 2.15 0.60 ! -10.81 -20.64 to 0.23 0.06 ! -7.57 -15.25 to 0.8 0.08 
Midpoint of Q4 1.10 -1.08 to 3.32 0.33 ! -21.06 -32.16 to -8.15 0.002 ! -10.25 -19.8 to 0.45 0.06 
P for Interaction†   0.38    0.01    0.43      
5 
Midpoint of Q1 -1.24 -3.63 to 1.2 0.32 ! 6.37 -9.99 to 25.69 0.47 ! 1.72 -10.17 to 15.19 0.79 
Midpoint of Q2 -0.31 -2.15 to 1.57 0.75 ! -3.71 -15.29 to 9.45 0.56 ! -3.62 -12.39 to 6.02 0.45 
Midpoint of Q3 0.48 -1.2 to 2.18 0.58 ! -11.31 -21.05 to -0.36 0.04 ! -7.82 -15.46 to 0.52 0.07 
Midpoint of Q4 1.81 -0.34 to 4 0.10 ! -22.79 -33.47 to -10.39 0.0007 ! -14.49 -23.45 to -4.47 0.006 P for Interaction†     0.05       0.003       0.03 
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    LF   HF 
Position Methylation % Change* 95% CI P   
% 
Change* 95% CI P 
1 
Midpoint of Q1 -11.35 -30.67 to 13.36 0.34 ! 1.00 -22.87 to 32.27 0.94 
Midpoint of Q2 -13.74 -28.64 to 4.28 0.13 ! -9.74 -26.73 to 11.19 0.34 
Midpoint of Q3 -15.64 -29.53 to 0.98 0.06 ! -17.68 -32.53 to 0.45 0.06 
Midpoint of Q4 -18.73 -36.26 to 3.64 0.10 ! -29.38 -46.1 to -7.48 0.01 
P for Interaction†   0.61    0.06          
2 
Midpoint of Q1 -17.70 -34.99 to 4.19 0.11 ! -5.94 -27.43 to 21.91 0.64 
Midpoint of Q2 -16.04 -30.54 to 1.48 0.07 ! -11.67 -28.3 to 8.83 0.24 
Midpoint of Q3 -14.72 -28.69 to 1.99 0.08 ! -15.90 -30.99 to 2.48 0.09 
Midpoint of Q4 -12.02 -30.33 to 11.11 0.28 ! -23.77 -41.18 to -1.22 0.04 
P for Interaction†   0.67    0.22          
3 
Midpoint of Q1 4.93 -18.73 to 35.46 0.71 ! 10.57 -16.54 to 46.49 0.48 
Midpoint of Q2 -6.44 -23.08 to 13.79 0.51 ! -4.44 -22.97 to 18.55 0.68 
Midpoint of Q3 -14.64 -28.62 to 2.06 0.08 ! -14.96 -30.18 to 3.58 0.11 
Midpoint of Q4 -26.97 -41.87 to -8.26 0.007 ! -30.26 -45.83 to -10.2 0.005 
P for Interaction†   0.03    0.01 
  
! ! !
    
4 
Midpoint of Q1 -12.69 -31.92 to 11.98 0.29 ! -0.15 -24.04 to 31.25 0.99 
Midpoint of Q2 -13.86 -29.23 to 4.84 0.14 ! -8.49 -26.31 to 13.62 0.42 
Midpoint of Q3 -14.86 -28.79 to 1.8 0.08 ! -15.14 -30.32 to 3.36 0.10 
Midpoint of Q4 -16.72 -33.93 to 4.96 0.12 ! -26.43 -42.95 to -5.13 0.02 
P for Interaction†   0.77    0.09          
5 
Midpoint of Q1 -1.26 -23.57 to 27.57 0.92 ! 15.29 -12.68 to 52.22 0.32 
Midpoint of Q2 -9.27 -25.47 to 10.46 0.33 ! -3.32 -21.96 to 19.78 0.76 
Midpoint of Q3 -15.39 -29.24 to 1.17 0.07 ! -16.41 -31.27 to 1.68 0.07 
Midpoint of Q4 -24.79 -40.16 to -5.46 0.01 ! -34.57 -49.1 to -15.88 0.001 
P for Interaction†     0.10       0.002 
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HR indicates heart rate; rMSSD indicates the root mean square of successive differences; SDNN indicates the standard deviation of 
normal-to-normal intervals; LF indicates low-frequency power (0.04 –0.15 Hz); HF indicates high-frequency power (0.15–0.4 Hz); CI 
indicates confidence interval; Q1, Q2, Q3, and Q4 indicate the 1st, 2nd, 3rd, and 4th quartile. 
   *The percent change in HRV per 10 !g/m3 increase in PM2.5 concentration. Results were adjusted for age; body mass index; fasting glucose 
level; hypertension; smoking status; alcohol consumption; physical exercise; household income; the use of calcium channel blocker, "-
blocker, and angiotensin-converting enzyme inhibitor; room temperature; outdoor apparent temperature; season; weekday; and visit date. 
†To examine effect modification by position-specific TLR2 methylation, an interaction term between position-specific TLR2 methylation and 
PM2.5 was included in the model.
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Figure 3.4. Effect of dietary flavonoid (N=497) and folic acid (N=482) intake on mean and position-specific Toll-like Receptor 2 
(TLR2) methylation  
 
IQR indicates interquartile-range. Results were adjusted for age, body mass index, total caloric intake, total vitamin C intake, total 
fiber intake, smoking status, household income, and physical activity. 
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Table 3.6. Effect of dietary flavonoid intake on mean and position-specific Toll-like Receptor 2 (TLR2) 
methylation, adjusted for total fruit and vegetable intake  
 
  Original model  (N=497)*   
Adjusted for total fruit and vegetable intake  
(N=482)† 
  % Change 95% CI P   % Change  95% CI P 
Position 1 -10.02 -17.37 to -2.66 <0.01 
 
-8.47 -15.94 to -1.01 0.03 
Position 2 -3.81 -10.31 to 2.69 0.25 
 
-2.51 -9.33 to 4.30 0.48 
Position 3 -4.49 -12.11 to 3.14 0.25 
 
-4.28 -12.11 to 3.55 0.28 
Position 4 -6.05 -12.74 to 0.65 0.08 
 
-6.61 -13.51 to 0.29 0.06 
Position 5 -3.31 -14.26 to 7.64 0.55 
 
-4.82 -16.12 to 6.48 0.41 
Mean -5.09 -10.06 to -0.12 0.05   -4.99 -10.16 to 0.17 0.06 
*Results were adjusted for age, year of visit, body mass index, total caloric intake, total vitamin C intake, 
total fiber intake, smoking status, household income, and physical activity. 
†In addition to all the covariates in the original model except total vitamin C and fiber intake, results were 
adjusted for total fruit and vegetable intake. 
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Figure 3.5. Effect of dietary vitamin B12 (N=497) and methionine (N=482) intake on mean and position-specific Toll-like Receptor 2 
(TLR2) methylation  
 
IQR indicates interquartile-range. Results were adjusted for age, body mass index, total caloric intake, total vitamin C intake, total 
fiber intake, smoking status, household income, and physical activity. 
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Table 3.7. The effect of particulate matter with aerodynamic diameter < 2.5 micrometers 
(PM2.5) exposure on heart rate variability (HRV) at different daily flavonoid intake level, 
Normative Aging Study, 2000-2011 (N=513) 
  HR 
Flavonoid Intake  % Change* 95% CI P 
Midpoint of Q1 (128 mg/d) 0.06 -1.65 to 1.80 0.95 
Midpoint of Q2 (228 mg/d) 0.00 -1.51 to 1.53 1.00 
Midpoint of Q3 (370 mg/d) -0.09 -1.45 to 1.30 0.90 
Midpoint of Q4 (673 mg/d) -0.26 -1.98 to 1.48 0.76 
P for Interaction   0.76 
  rMSSD 
Flavonoid Intake  % Change* 95% CI P 
Midpoint of Q1 (128 mg/d) -5.32 -16.91 to 7.88 0.41 
Midpoint of Q2 (228 mg/d) -4.94 -15.25 to 6.62 0.39 
Midpoint of Q3 (370 mg/d) -4.41 -13.82 to 6.03 0.39 
Midpoint of Q4 (673 mg/d) -3.25 -15.28 to 10.49 0.63 
P for Interaction     0.79 
!
SDNN 
Flavonoid Intake  % Change* 95% CI P 
Midpoint of Q1 (128 mg/d) -6.14 -14.57 to 3.11 0.19 
Midpoint of Q2 (228 mg/d) -5.22 -12.74 to 2.95 0.20 
Midpoint of Q3 (370 mg/d) -3.89 -10.81 to 3.56 0.30 
Midpoint of Q4 (673 mg/d) -1.00 -10.03 to 8.93 0.84 
P for Interaction     0.37 
 
LF 
Flavonoid Intake  % Change* 95% CI P 
Midpoint of Q1 (128 mg/d) -16.48 -31.35 to 1.61 0.07 
Midpoint of Q2 (228 mg/d) -12.55 -26.37 to 3.87 0.13 
Midpoint of Q3 (370 mg/d) -6.65 -20.07 to 9.03 0.39 
Midpoint of Q4 (673 mg/d) 7.31 -12.16 to 31.11 0.49 
P for Interaction     0.05 
!
HF 
Flavonoid Intake  % Change* 95% CI P 
Midpoint of Q1 (128 mg/d) -10.42 -28.69 to 12.54 0.34 
Midpoint of Q2 (228 mg/d) -7.78 -24.49 to 12.63 0.43 
Midpoint of Q3 (370 mg/d) -3.89 -19.74 to 15.09 0.67 
Midpoint of Q4 (673 mg/d) 4.96 -16.93 to 32.63 0.68 
P for Interaction     0.28 
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HR indicates heart rate; rMSSD indicates the root mean square of successive 
differences; SDNN indicates the standard deviation of normal-to-normal intervals; LF 
indicates low-frequency power (0.04 –0.15 Hz); HF indicates high-frequency power 
(0.15–0.4 Hz); CI indicates confidence interval; Q1, Q2, Q3, and Q4 indicate the 1st, 2nd, 
3rd, and 4th quartile. 
Results were adjusted for age; body mass index; total caloric intake; total vitamin C 
intake; total fiber intake; fasting glucose level; hypertension; smoking status; alcohol 
consumption; physical exercise; household income; the use of calcium channel blocker, 
!-blocker, and angiotensin-converting enzyme inhibitor; room temperature; outdoor 
apparent temperature; season; weekday; and visit date.  
*The percent change in HRV per 10 "g/m3 increase in PM2.5 concentration. 
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Figure 3.6. The effect of particulate matter with aerodynamic diameter < 2.5 micrometers (PM2.5) exposure on heart rate variability 
(HRV) at different flavonoid intake levels, Normative Aging Study, 2000-2011 (N=513) 
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log10HR indicates log10-transformed heart rate; log10rMSSD indicates log10-transformed root mean square of the successive 
differences; log10SDNN indicates log10-transformed standard deviation of normal-to-normal intervals; log10LF indicates log10-
transformed low-frequency power (0.04 –0.15 Hz); log10HF indicates log10-transformed high-frequency power (0.15–0.4 Hz); Q1, Q2, 
Q3, and Q4 indicate the 1st, 2nd, 3rd, and 4th quartiles.  
The association of PM2.5 on rMSSD, SDNN, LF, and HF is modified by flavonoid intake, as indicated by the different slopes. The four 
lines in each figure represent the relationship between PM2.5 and HRV when the flavonoid intake at the midpoints of each quartile. If 
there was no effect modification, the four lines would be the same. Results were adjusted for age; body mass index; total caloric intake; 
total vitamin C intake; total fiber intake; fasting glucose level; hypertension; smoking status; alcohol consumption; physical exercise; 
household income; the use of calcium channel blocker, !-blocker, and angiotensin-converting enzyme inhibitor; room temperature; 
outdoor apparent temperature; season; weekday; and visit date . 
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effect was seen for the 2nd, 3rd, and 4th flavonoid quartile (Table 3.7). The effect modification by 
flavonoid intake was abrogated when mean TLR2 methylation and the interaction between mean 
TLR2 methylation and PM2.5 exposure were fitted in the model (Table 3.8). 
 
Correlation of Plasma Inflammatory Markers with TLR2 methylation 
Increased TLR2 methylation level was consistently correlated with increased plasma ICAM-1 
level, across five CpG positions (P<0.0001, P<0.0001, P=0.0002, P=0.0004, P=0.0003, 
respectively) (Table 9). IL8 and VEGF were also positively correlated with TLR2 methylation 
level at position 3(P=0.01, P=0.02, respectively) (Table 3.9). 
 
Sensitivity Analyses 
The major sources of dietary flavonoids and folic acid are fruits and vegetables, which contain 
other nutrients that are likely to affect DNA methylation. Therefore, in sensitivity analysis of 
models including flavonoids, we adjusted for daily total fruit and vegetable intake—instead of 
total vitamin C and fiber intake—to examine the robustness of our findings. This adjustment 
only resulted in minor changes in the effect estimates for the association between flavonoid and 
TLR2 methylation, as well as of the effect modification by flavonoid of the effect of PM2.5 
exposure on HRV (Tables 3.6 and 3.8). 
 
Due to the high tissue and cell-type specificity of DNA methylation, DNA methylation in whole 
blood might be affected by differences in the proportions of leukocyte cell types.36 We therefore 
examined the correlation between the percentage of specific leukocyte types (i.e., eosinophils, 
lymphocytes, neutrophils, monocytes, and basophils) and TLR2 methylation level. Among these 
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five leukocyte types, the percentage of lymphocytes and neutrophils in total blood cells were 
correlated with TLR2 methylation (Table 3.10). Therefore, we performed sensitivity analysis 
adjusted for lymphocyte and neutrophil percentages. Our findings were not affected by this 
adjustment (Table 3.11).   
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Table 3.8. Effect modification by flavonoid intake on the association between particulate matter with aerodynamic diameter < 2.5 
micrometers (PM2.5) exposure and heart rate variability (HRV), adjusted for total fruit and vegetable intake, and adjusted for mean 
Toll-like Receptor 2 (TLR2) methylation 
  Original model (N=513)*   Adjusted for total fruit and vegetable intake (N=482)†   
Adjusted for mean TLR2 
methylation (N=423)‡ 
HRV 
measure 
% 
Change§ 95% CI 
P for 
Interaction 
  
% 
Change§ 95% CI 
P for 
Interaction   
% 
Change§ 95% CI 
P for 
Interaction 
HR -0.18 -1.32 to 0.98 0.76 
 -0.30 -1.48 to 0.90 0.62  0.89 
-0.72 to 
2.52 0.30 
rMSSD 1.17 -7.38 to 10.51 0.79 
 0.67 -8.45 to 10.7 0.89  0.07 
-11.28 to 
12.87 0.99 
SDNN 2.98 -3.43 to 9.81 0.37 
! 2.77 -3.88 to 9.88 0.42 ! 2.28 
-6.49 to 
11.87 0.62 
LF 14.63 0.27 to 31.03 0.05 
! 15.81 0.50 to 33.45 0.04 ! 10.48 
-8.39 to 
33.24 0.30 
HF 8.98 -6.93 to 27.62 0.28 
  7.65 -9.17 to 27.59 0.40   7.65 
-12.28 to 
32.10 0.48 
HR indicates heart rate; rMSSD indicates the root mean square of successive differences; SDNN indicates the standard deviation of 
normal-to-normal intervals; LF indicates low-frequency power (0.04 –0.15 Hz); HF indicates high-frequency power (0.15–0.4 Hz); 
CI indicates confidence interval. 
*Results were adjusted for age; body mass index; total caloric intake; total vitamin C intake; total fiber intake; fasting glucose level; 
hypertension; smoking status; alcohol consumption; physical exercise; household income; the use of calcium channel blocker, !-
blocker, and angiotensin-converting enzyme inhibitor; room temperature; outdoor apparent temperature; season; weekday, and visit 
date.  
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†In addition to all the covariates in the original model except total vitamin C and fiber intake, results were adjusted for total fruit 
and vegetable intake. 
‡In addition to all the covariates in the original model, results were adjusted for mean TLR2 methylation, and the interaction between 
mean TLR2 methylation and PM2.5 concentration.  
§The additional percent change in HRV associated with 10 "g/m3 PM2.5 concentration, compared to participants with one interquartile 
range lower flavonoid intake level.  
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Table 3.9. Correlation between mean blood Toll-like Receptor 2 (TLR2) methylation and plasma inflammatory markers 
 
TLR2 methylation, 
Position 1 
 
TLR2 methylation, 
Position 2 
 
TLR2 methylation, 
Position 3 
 
TLR2 methylation, 
Position 4 
 
TLR2 methylation, 
Position 5 
 
Correlation 
Coefficient 
P*     
Correlation 
Coefficient 
P*     
Correlation 
Coefficient 
P*     
Correlation 
Coefficient 
P*     
Correlation 
Coefficient 
P*   
IL6 -0.067 0.08 
 
-0.025 0.52 
 
0.067 0.08 
 
0.040 0.30 
 
0.020 0.60 
IL8 -0.004 0.93 
 
0.006 0.88 
 
0.095 0.01 
 
0.053 0.17 
 
0.049 0.20 
IL1" -0.031 0.42 
 
0.040 0.31 
 
0.046 0.23 
 
0.019 0.63 
 
0.015 0.70 
TNF# -0.043 0.27 
 
-0.056 0.15 
 
0.006 0.87 
 
-0.009 0.81 
 
-0.039 0.32 
TNF$ -0.030 0.44 
 
-0.007 0.86 
 
-0.017 0.66 
 
-0.029 0.45 
 
-0.022 0.58 
CRP 0.032 0.35 
 
-0.007 0.85 
 
0.011 0.76 
 
0.024 0.49 
 
0.047 0.17 
ICAM-1 0.138 <0.0001 
 
0.159 <0.0001 
 
0.127 0.0002 
 
0.123 0.0004 
 
0.124 0.0003 
VEGF -0.022 0.57   -0.016 0.68   0.091 0.02   0.050 0.20   0.046 0.24 
 
IL indicates interleukin; TNF indicates tumor necrosis factor; CRP indicates C-reactive protein; ICAM-1 intercellular adhesion molecule 1; VEGF 
indicates vascular endothelial growth factor. 
*P value represents Prob > |r| under H0: Rho (Spearman's rank correlation coefficient) = 0 
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Table 3.10. Correlation between mean blood Toll-like Receptor 2 (TLR2) 
methylation level and proportions of different leukocyte cell types 
  Spearman correlation with mean TLR2 methylation* 
 Cell Type Correlation Coefficient P†   
 Eosinophils (%) 0.051 0.145 
 Lymphocytes (%) 0.121 0.001 
 Neutrophils (%) -0.118 0.001 
 Monocytes (%) 0.018 0.604 
 Basophils (%) 0.012 0.730 
 *Mean TLR2 methylation level across five CpG sites. 
†P value represents Prob > |r| under H0: Rho (Spearman's rank correlation 
coefficient) = 0
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Table 3.11. Effect modification by position-specific Toll-like Receptor 2 (TLR2) methylation level, 
on the association between particulate matter with aerodynamic diameter < 2.5 micrometers (PM2.5) 
exposure and heart rate variability (HRV), adjusted for cell types 
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  HR 
Position % Change
§, Original model, 
N=500*  
% Change§, Adjusted for cell types, 
N=498† 
1 0.05  0.03 
2 0.17  0.26 
3 0.53  0.60 
4 0.36  0.44 
5 0.83‡   0.85‡ 
!
rMSSD 
Position % Change
§, Original model, 
N=500*  
% Change§, Adjusted for cell types, 
N=498† 
1 -10.07‡  -9.64‡ 
2 -5.60‡  -6.10‡ 
3 -7.35‡  -7.45‡ 
4 -6.55‡  -6.48‡ 
5 -8.29‡   -7.88‡ 
!
SDNN 
Position % Change
§, Original model, 
N=500*  
% Change§, Adjusted for cell types, 
N=498† 
1 -5.34‡  -5.01‡ 
2 -0.34  -0.72 
3 -3.87‡  -3.97‡ 
4 -1.62  -1.56 
5 -4.58‡   -4.21‡ 
!
LF 
Position % Change
§, Original model, 
N=500*  
% Change§, Adjusted for cell types, 
N=498† 
1 -2.45  -1.65 
2 1.75  1.39 
3 -8.77‡  -8.90‡ 
4 -1.22  -1.23 
5 -7.09   -6.46 
!
HF 
Position % Change
§, Original model, 
N=500*  
% Change§, Adjusted for cell types, 
N=498† 
1 -9.72  -8.72 
2 -5.31  -6.35 
3 -11.01‡  -11.31‡ 
4 -7.63  -7.74 
5 -14.20‡   -13.33‡ 
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HR indicates heart rate; rMSSD indicates the root mean square of successive differences; SDNN 
indicates the standard deviation of normal-to-normal intervals; LF indicates low-frequency power 
(0.04 –0.15 Hz); HF indicates high-frequency power (0.15–0.4 Hz). 
*Results were adjusted for age, body mass index, fasting glucose level, hypertension, smoking 
status, alcohol consumption, physical exercise, household income, medication use (!-blocker, 
calcium channel blocker, ace inhibitor), room temperature, outdoor apparent temperature, season, 
weekday, and visit date. 
†Results were adjusted for all covariates in the original model and the percentage of neutrophil 
and lymphocyte. 
‡P " 0.05, statistically significant 
§The additional percent change in HRV associated with 10 #g/m3 increase in PM2.5 concentration, 
compared to participants with one %5mC lower TLR2 methylation level. 
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DISCUSSION AND CONCLUSION 
This study on a cohort of aging male Boston-area residents demonstrated the adverse impact of 
short-term PM2.5 exposure estimated at the home address on HRV. In addition, novel findings 
showed that individuals with higher methylation in the TLR2 gene promoter are more susceptible 
to reduced HRV after PM2.5 exposure, compared to those with lower methylation levels. Further, 
higher flavonoid intake in the year preceding the examination significantly lowered TLR2 
methylation, and attenuated the association between PM2.5 exposure and the LF measure of HRV. 
 
PM exposure is a modifiable factor that contributes to cardiovascular morbidity and mortality, 
particularly in the acute exposure period, as emphasized by the recent AHA statement on air 
pollution.2 Consistent with our previous study,30 we observed the strongest effect on HRV from 
PM2.5 among major types of air pollutants. The negative association between short-term PM2.5 
exposure and HRV has been repeatedly observed in general population samples,37 cardiac and 
hypertensive patients,38 asthmatic adults,39 young adults,40 and older adults,4,30 as well as in a 
recent meta-analysis of 29 different studies (N=18,667).41 The present study showed effects of 
PM2.5 exposure across four different indices of HRV, but not on HR. This finding suggests that 
short-term PM2.5 exposure may affect the cardiac inter-beat intervals before any appreciable 
influence is detected on heart rate. SDNN, a marker of the cyclic components, represents the 
total variability over the seven minutes of ECG monitoring. LF variability is linked to the 
activity of both sympathetic and parasympathetic nervous system, whereas HF and rMSSD are 
sensitive to high-frequency heart period fluctuations and reflect the parasympathetic nervous 
activity. The HRV reductions associated with PM2.5 in these four indices may reflect 
pathophysiological changes in cardiac autonomic balance following exposure, which could be a 
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potential mechanism linking air pollution and cardiac morbidity and mortality in the aging 
population.5  
 
Many epidemiological studies4,30 have presented a wide inter-individual variability in responses 
to short-term air pollution, possibly due to biological characteristics.7 For example, preexisting 
cardiac conditions, diabetes, and polymorphism of genes involved in endothelial function may 
confer higher susceptibility to autonomic dysfunction induced by PM2.5 exposure.4, 30 However, 
these characteristics are either non-modifiable or already well-recognized conditions with 
specific treatment guidelines. This study revealed that increased TLR2 methylation is linked with 
intensified inflammatory responses, as reflected in elevated plasma IL8, ICAM-1, and VEGF 
level. In addition, we demonstrated that low TLR2 methylation, an epigenetic mechanism 
ensuring immunoregulation, reduces the adverse effects of PM2.5 exposure on HRV. TLR2 
provides a critical line of protection by inducing Tregs to limit immune-mediated damage.13,14 
Netea et al. reported a 50% decrease in the number of CD4+CD25+ Treg cells accompanied by 
an impaired release of immunosuppressive cytokines in TLR2 null mice compared with wild-type 
mice, demonstrating the role of TLR2 in immunoregulation.14 These findings support our 
hypothesis that high TLR2 methylation, an epigenetic process associated with suppressed TLR2 
expression, conveys susceptibility to PM exposure-induced HRV reductions by decreasing 
immunoregulation.  
 
Our data presented notable effect heterogeneity across the five CpG positions within TLR2 
promoter region. The distance from position 1 to position 5 is less than 20 base pairs, thus these 
sites are likely to share most of the same functional complexes and traits, i.e. CpG islands, 
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DNaseI hypersensitivity, nuclease accessibility and histone modifications (UCSC genome 
browser) (Figure 2). However, differential methylation patterns across five positions have been 
observed in the ENCODE project, as identified by the Illumina Infinium Human Methylation 
450 Bead Array platform. This suggests that variable methylation patterns exist at these sites 
even though the CpGs share common functional complexes.  
 
TLR2 methylation is sensitive to dietary and other behavioral factors.42 In particular, flavonoids, 
a major subtype of polyphenols, are established inhibitors for methylation-induced gene 
silencing.17,18 Flavonoids inhibit the activity of DNA methyltransferase in a dose-response 
manner, reverse DNA methylation and can reactivate silenced genes.17,18,43 Our study showed 
that dietary flavonoid intake over the previous year is negatively associated with TLR2 
methylation, indicating that adequate flavonoid intake may be essential to maintain a low, 
protective TLR2 methylation level. In addition, we showed that increased flavonoid intake 
alleviates the adverse effect of PM2.5 exposure on LF, and the effect modification is diminished 
when the model is adjusted for TLR2 methylation. This finding suggests that, at least in part, the 
average daily flavonoid intake over the preceding year affects individual susceptibility to post-
exposure HRV reduction by modulating TLR2 methylation level. However, formal mediation 
analysis was not performed in the present study due to the lack of appropriate statistical 
methodology to identify the potential pathway between two effect modifiers in repeated measure 
data.  
 
We also investigated a group of methyl nutrients including folic acid, vitamin B12, and 
methionine, which are essential component in the one-carbon metabolism pathway that is 
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expected to favor higher blood DNA methylation.19 However, no evidence to date demonstrates 
whether methyl nutrients can specifically modulate immune genes.44 Our analysis did not show 
significant correlation between methyl nutrients intakes and TLR2 methylation status. In our 
previously published study, PM2.5 was negatively associated with heart rate variability in 
subjects with lower vitamin B12, and methionine intakes, but not in the higher intake groups. 
Our findings indicated that the effect modification reported in our previous study by vitamin B12 
and methionine intake is likely to act through a different mechanism, independent of TLR2 
methylation. 
 
This study has several strengths, including its prospective study design and relatively large 
sample size that enabled us to determine effect modifications by TLR2 methylation and flavonoid 
intakes. To demonstrate the power of the present study, we performed simulation-based power 
calculation using linear mixed effect models with compound symmetry covariance structure, 
accounting for covariates adjustments. Specifically, we generated 1000 simulated datasets, each 
with N= 500 independent subjects, in which each subject had two (correlated) observations. The 
exposure, effect modifier and outcome were assumed to be normally distributed. A random 
intercept linear mixed effect model (with compound symmetry correlation structure) was then 
fitted to each of the simulated datasets. Using effect sizes for both main effect of PM2.5 exposure 
and the effect modification after adjustment for covariates estimated from our data, we expected 
to have >90% power to detect the observed main effect of PM on HRV indices, and >80% power 
to detect the observed effect modification by TLR2 methylation and flavonoid intakes at 
alpha=0.05 level. Exposure misclassification, which is inherent in epidemiological studies on air 
pollution, is a limitation of the present study. Most previous studies relied on a few monitoring 
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sites in the study area as surrogates for recent PM2.5 exposure history; that approach introduced 
measurement errors leading to underestimation of the effect.45 We reduced misclassification by 
using a novel, validated, hybrid prediction model to assess temporally and spatially resolved 
PM2.5 exposure level,24 and the observed effect size of PM2.5 exposure on HRV is larger 
compared to previous study from the same cohort using monitoring site data.4 This prediction 
model accounted for the spatial variability of PM2.5 concentration within the study area and 
produced more accurate estimates of recent PM2.5 exposure at a 10 x 10 km resolution. The 
Boston metropolitan area comprises 15 corresponding model grid cells, and the use of the cell-
specific predictions for each participant enabled us to assign different exposure levels to 
participants on a relatively small grid based on their residential areas.26 Although measurement 
error cannot be completely avoided, it was unlikely to be associated with participants’ HRV 
status. Therefore, misclassification is likely non-differential and is expected to bias our result 
towards the null. Acknowledging that confounding is a critical concern in any observational 
study; we included in regression models an extensive list of covariates. We conducted further 
analysis to evaluate the sensitivity of our results to covariate specification, and our results were 
stable and robust. We also examined the correlation between 48-hour and 1-year moving average 
of PM2.5 to rule out the possibility that the observed effect was partially due to correlation of the 
48-hour moving average with long-term exposure to PM2.5. These two exposure metrics were not 
correlated (R2 = 0.07); therefore the association between the 48-hour moving average of PM2.5 
and HRV was unlikely to be confounded by long-term PM2.5 exposure. In addition, all HRV 
measures were conducted at the same time of the day to eliminate confounding due to diurnal 
variation. While residual confounding due to unmeasured variables is not unlikely, chances that 
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the observed association and effect modification reflected bias resulting from residual 
confounding are minimized.  
 
We acknowledge several other limitations in the present study. During the follow-up of the 
present study – when data on PM exposure is available – there were 636 eligible NAS 
participants (Figure 1). However, our analysis only included a study population of 573 
participants due to missing PM exposure or HRV data. To examine if the final analysis sample is 
different from the eligible population, we compared key baseline characteristics (age, race, 
physical activity, alcohol consumption, smoking status, hypertension, diabetes, and household 
annual income) between participants excluded in the final analysis due to missing exposure or 
outcome (N=63) and the participants for final analysis (N=573) and no significant difference was 
observed (data not shown). In addition, in the analysis investigating effect modification by TLR2 
methylation, 73 participants out of 573 were excluded due to lack of DNA samples for 
methylation analysis. In the analysis of flavonoid intake and TLR2 methylation, 60 participants 
out of 573 were excluded due to lack of FFQ data. However, based on the study operations, it is 
reasonable to assume that the missingness was independent of participants’ exposure level, HRV 
status, and methylation states. We compared the HRV measures between those with complete 
data (N=500/N=513) and those without (N=73/N=60), and no apparent difference was observed 
(data not shown). Therefore, selection bias due to informative missingness in this study was 
unlikely. Both the within-person and between-person effects contributed to the effect 
modification by TLR2 methylation. However, during the study period, the effect modification by 
TLR2 methylation was mostly due to between-person effects, as when the models were adjusted 
for subject id, the significance of effect modification was diminished (data not shown). Due to 
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the limited number of within-subject repeated visits, we were unable to identify the exact 
magnitude of effect modification by TLR2 methylation within subject. In addition, our findings 
are limited to male older individuals who were residing in a lightly-polluted urban area. 
Therefore, the conclusion might not be generalizable to young adults, females, or people living 
in other areas due to differential environmental and physiological factors.  
 
Finally, alveolar inflammation and the subsequent systemic inflammation are essential, but not 
the only mechanism linking PM2.5 exposure and cardiac dysfunction. For example, particles may 
perturb the autonomic nervous system balance via interaction with lung receptors; a small 
fraction of PM (ultrafine particles, and some PM constituents such as organic compounds and 
metals) may translocate into the systemic circulation.2 Due to the less than comprehensive 
analysis on plasma inflammatory marker profile and limited sample size, we were unable to draw 
definite conclusion on the mechanistic pathway underlying the protective effect of low TLR2 
methylation status and high flavonoid intake. Future studies are warranted to identify the precise 
pathophysiological processes of PM-induced cardiovascular responses, as well as the 
mechanistic underpinnings of the effect of TLR2 methylation and dietary flavonoid intake. 
 
The U.S. is an aging society and older people are especially susceptible to air pollution-triggered 
cardiovascular disease. As air pollution remains an important ubiquitous public health threat, 
PM2.5-associated HRV reduction is an alarming signal of influences on the autonomic regulation 
of heart rate in older people. These alterations may represent a primary sentinel effect to identify 
the influence of PM2.5 among older individuals or even reflect intermediate mechanisms that may 
favor acute cardiovascular events.2,3 Providing preventive strategies at the individual level is 
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especially important in cardiovascular research, which was recognized as an important new 
emphasis in the AHA statement on air pollution.2 Our study provides a novel perspective on 
individual susceptibility to adverse cardiovascular effects following short-term air pollution; our 
findings suggest high TLR2 methylation as a modifiable “epigenetic predisposition” for 
cardiovascular responses that are associated with short-term PM2.5 exposure in older people. In 
addition, based on our data, increasing flavonoid intake—which could be achieved by increasing 
intake of one or more of the major sources of dietary flavonoids (tea, beans, wine, berries, and 
citrus fruits)—may help maintain a low TLR2 methylation level and mitigate PM2.5 exposure-
induced cardiovascular system impairment.  
 
In summary, our findings suggest that the epigenetic regulation of TLR2-related immunity may 
determine vulnerability of older individuals when confronted with air pollution peaks, and that 
adequate dietary flavonoid intake may ensure a protective epigenetic status against the adverse 
effects of PM2.5 exposure.  
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Ambient PM2.5 pollution is a major public health challenge facing the world today.1 The unclear 
mechanistic underpinning of PM2.5’s health effects remains the major gap in current knowledge – 
therefore creating enormous challenges to develop preventative strategies. In Chapter one and 
two, we conducted the first human intervention trial, investigating novel mechanistic pathway 
linking air pollution and adverse health effects, and potential targeted preventive approaches.  
Our study for the first time provide experimental evidence showing that ambient PM2.5 exposure 
peak has unfavorable effect on cardiac autonomic function, the immune system, and the 
epigenome – which, can be counteracted by B vitamins supplementation. Our findings suggest 
promising opportunities to aid the development of novel pharmaceutical intervention strategies – 
which is particularly important to reduce the burden of pathologies related to ubiquitous 
exposures such as PM2.5 pollution.  
 
The U.S. is an aging society and older people are especially susceptible to air pollution-triggered 
cardiovascular disease. In chapter three, we showed that PM2.5 induced HRV reduction, an 
alarming signal of influences on the autonomic regulation of heart rate in older people. These 
alterations may represent a primary sentinel effect to identify the influence of PM2.5 among older 
individuals or even reflect intermediate mechanisms that may favor acute cardiovascular events. 
Furthermore, our findings suggest that the epigenetic regulation of TLR2-related immunity may 
determine vulnerability of older individuals when confronted with air pollution peaks, and that 
increasing flavonoid intake—which could be achieved by increasing intake of one or more of the 
major sources of dietary flavonoids (tea, beans, wine, berries, and citrus fruits)—may help 
maintain a low TLR2 methylation level and mitigate PM2.5 exposure-induced cardiovascular 
system impairment. !
